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Abstract 
 
The major goal for physicochemical screening of pharmaceuticals is to predict human 
drug absorption, distribution, elimination, excretion and toxicity. These are all dependent on 
the lipophilicity of the drug, which is expressed as a partition coefficient i.e. a measure of a 
drug’s preference for the lipophilic or hydrophilic phases. The most common method of 
determining a partition coefficient is the shake flask method using octanol and water as 
partitioning media. However, this system has many limitations when modeling the interaction 
of ionised compounds with membranes, therefore, unreliable partitioning data for many solutes 
has been reported. In addition to these concerns, the procedure is tedious and time consuming 
and requires a high level of solute and solvent purity. Micellar liquid chromatography (MLC) 
has been proposed as an alternative technique for measuring partition coefficients utilising 
surfactant aggregates, known as micelles. 
This thesis investigates the application of MLC in determining micelle-water partition 
coefficients (logPMW) of pharmaceutical compounds of varying physicochemical properties. 
The effect of mobile phase pH and column temperature on the partitioning of compounds was 
evaluated. Results revealed that partitioning of drugs solely into the micellar core was 
influenced by the interaction of charged and neutral species with the surface of the micelle. 
Furthermore, the pH of the mobile phase significantly influenced the partitioning behaviour 
and a good correlation of logPMW was observed with calculated distribution coefficient (logD) 
values. More interestingly, a significant change in partitioning was observed near the 
dissociation constant of each drug indicating an influence of ionised species on the association 
with the micelle and retention on the stationary phase. Elevated column temperatures 
confirmed partitioning of drugs considered in this study was enthalpically driven with a small 
change in the entropy of the system because of the change in the nature of hydrogen bonding. 
Finally, a quantitative structure property relationship was developed to evaluate biological 
relevance in terms of predicting skin permeability of the newly developed partition coefficient 
values. This study provides a better surrogate for predicting skin permeability based on an easy, 
fast and cheap experimental methodology, and the method holds the predictive capability for a 
wider population of drugs. 
In summary, it can be concluded that MLC has the ability to generate partition 
coefficient values in a shorter time with higher accuracy, and has the potential to replace the 
octanol-water system for pharmaceutical compounds.  
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Chapter 1: An introduction to partition coefficients 
and micellar liquid chromatography 
 
 
In the pharmaceutical industry, formulation of a new drug substance into a final dosage 
form requires substantial physical and chemical characterisation. For this purpose, 
preformulation studies are designed including the measurement of partition coefficients. 
Partition coefficient measurements also contribute to understanding the rate and extent of drug 
absorption. The partition coefficient is a measure of a drug’s preference for the lipophilic or 
hydrophilic phases. When a drug substance is added in a mixture of two immiscible liquids, it 
distributes itself between the two phases and ultimately attains equilibrium at constant 
temperature. Transport of drug molecules across a biological membrane is governed by two 
processes; active and passive transport where active transport requires cellular energy while 
passive transport is related to the lipophilicity of the drug. As drugs have to pass through the 
biological membranes, which are composed of lipids and proteins, these membranes form a 
barrier for drugs (Dearden, 1985). 
 
1.1. The importance of partition coefficients 
 
Partition coefficients are often described as a measure of a compound’s preference to 
reside in lipophilic and hydrophilic environments (Pliška et al., 2008). Being a physicochemical 
property, partition coefficients are of prime importance in drug discovery and development. 
The term ‘lipophilicity’ refers to the affinity of a molecule for a lipophilic environment 
(Everett, 1972), while ‘hydrophilicity’ refers to the affinity of a molecule for a hydrophilic 
environment. Lipophilicity or hydrophilicity is frequently measured through distribution of 
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molecules between biphasic systems; the most commonly used is an octanol-water system 
(Sangster, 1989). Lipophilicity is relevant in pharmacological studies, for example, absorption, 
distribution, metabolism and excretion (ADME) profiling (Van, 1987; Van de Waterbeemd et 
al., 2001; Oprea, 2002), the transport of molecules through cellular membranes (Avdeef, 2001) 
and in the assessment of environmental fate, toxicology and transport of organic chemicals 
(Duffus, 1993).   
 
Historically, the importance of lipophilicity in connection with the biological activity 
of drugs was highlighted by Meyer (1899) and then Overton (1901) in their published work on 
nacrosis using oil-water partition coefficients for the first time. This was followed by Guadette 
and Brodie (1959), who found a correlation between heptane-water partition coefficients of 
some drugs and penetration rate through the blood brain barrier. The first systematic research 
on partition coefficients was organised by Hansch and Fujita (1964) and then by Leo and co-
workers (1971), introducing the octanol-water partition coefficient system as a reference to 
construct a quantitative structure-activity relationship (QSAR), known as Hansch analysis. 
This quantitative descriptor of lipophilicity, the partition coefficient (P) often expressed in its 
logarithmic form of logP, can be defined as the ratio of neutral species in organic (HAoct) and 
aqueous (HAaq) phases under equilibrium conditions, as expressed by Eq. (1.1): P = [��]೚��[��]�೜                                                                                                                        (1.1) 
Lipophilicity is known to be pH dependent, therefore it is crucial to determine partition 
coefficients at a range of pH values in order to get an appropriate predictor of biological 
activity. Hence, if the partition coefficients for neutral (P) and ionic (Pi) species are known, 
mathematically derived theoretical equations can be used to calculate the change in 
lipophilicity with respect to pH. 
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In the case of ionisable species, the term ‘distribution coefficient (D)’ is often used. For 
non-ionisable species, only the neutral form exists, therefore, P and D should be the same value. 
However, for ionisable species, there is a clear distinction between the partition and distribution 
coefficients in the pH range where these species exists in ionic forms (Kah and Brown, 2008). 
Mathematically, it can be expressed as: P = [��]೚��[��]�೜ ≈ D = [��]೚��+[��−]೚��[��]�೜ +[��−]�೜                                                                      (1.2) 
where Aiˉ is the concentration of the ionised species in octanol and the aqueous phase at a given 
pH. Assuming that only the neutral form of a species is present in the organic phase i.e. [Ai-]oct 
= 0, a value for D for an acidic compound can be derived from the pH and pKa relationship: D = ୔ଵ+ଵ଴ሺ೛�−p��ሻ                                                                                                             
  
(1.3) 
Similarly, for basic compounds:  D = ୔ଵ+ଵ଴ሺ೛��−೛Hሻ                                                                                            
   
(1.4) 
 
However, there is evidence that there is the presence of ionic species in the organic 
phase, thus a more complex approach is required to describe the distribution coefficient 
(Westall et al., 1985). In this case, the introduction of Pi (octanol-water partition coefficient for 
ionic species) is required, as highlighted in Eq. (1.5): Pi = [�−]೚��[�−]�೜                                                                                                                              (1.5) 
From equations (1.2) and (1.5), D can be more correctly defined as: D = P × [ܪ�] + Pi × [�−]  
Since: 
)(101
1][
apKpH
HA   and  1][][  AHA  
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D = ୔ଵ+ଵ଴ሺ೛�−p��ሻ + Pi × ቀͳ − ଵଵ+ଵ଴ሺ೛�−p��ሻቁ   D = ୔+୔i×ଵ଴ሺ೛�−p��ሻଵ+ଵ଴ሺ೛�−p��ሻ            (1.6) 
 
Similarly, for basic compounds: D = ୔+୔i×ଵ଴ሺp��−೛�ሻଵ+ଵ଴ሺp��−೛�ሻ                   (1.7) 
 
Furthermore, the same principles can be extended to any amphoteric species that have 
both acidic and basic functional groups (Kah and Brown, 2008) to permit determination of 
relevant data for such compounds. 
 
The octanol-water partition coefficient (logP) has been used as a physicochemical 
property as a descriptor of lipophilicity in a number of QSAR models. For example Hansch 
and co-workers (1987) elaborated the importance of a drug’s lipophilicity in crossing the blood 
brain barrier successfully. It has also been found that highly lipophilic drugs are slowly 
eliminated from the body and may elicit central nervous system related problems. More 
recently, work published by Potts and Guy (1992) successfully elaborated the relationship 
between a drug’s physicochemical properties, (for example lipophilicity and molecular weight) 
and permeability through the skin.  
 
Lipophilicity and hydrophobicity are often used interchangeably in the literature, 
however, the term lipophilicity is scientifically dissimilar from hydrophobicity. As described 
earlier, lipophilicity is the affinity of a molecule for a lipophilic environment whilst 
hydrophobicity is the association of non-polar groups or molecules in an aqueous environment. 
The latter phenomenon arises from the tendency of water to exclude non-polar molecules 
(Duffus, 1993; Rutkowska et al., 2013) and can be expressed in steric terms including molar 
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volume, polarisability and molar refractivity (Giaginis and Tsantili-Kakoulidou, 2008). 
Lipophilicity encodes two major structural contributions, namely a bulk term (reflecting cavity 
formation, hydrophobic and dispersive forces) and a polar term (reflecting electrostatic 
interactions and hydrogen bonding). The former term refers to hydrophobicity whilst the latter 
refers to polarity (Gaillard et al., 1994b). The partition coefficient is an equilibrium property 
between organic and aqueous phases, therefore, it describes a balance between hydrophobicity 
and polarity (Rutkowska et al., 2013). On the basis of polar/nonpolar inter- and intramolecular 
interactions, lipophilicity can therefore be expressed by Eq. (1.8): 
Lipophilicity =  Hydrophobicity - Polarity                (1.8) 
 
Changing the structural characteristics, for example the addition of substituents to 
aromatic or heterocyclic systems, conjugation within molecules or internal hydrogen bonds, 
affects intermolecular interactions, thus, influencing the lipophilicity (Bradshaw and Taylor, 
1989; Gago et al., 1994; Vrakas et al., 2003). Additionally, the polar and nonpolar 
environments presented by the solvent may result in conformational changes within the 
molecules, thus, rendering them more lipophilic or more hydrophilic than expected in the given 
solvent (Gaillard et al., 1994a; Tsantili-Kakoulidou et al., 1999). Furthermore, ionisation of 
molecules has a significant effect on intermolecular interactions, therefore, limiting the validity 
of additive rules established for neutral compounds (Caron and Ermondi, 2007; Dellis et al., 
2007). These issues are related to any biphasic system and are dependent on the solvent used. 
The difference among different biphasic systems, for example, octanol-water, gas-chloroform, 
chloroform-water, and water-alkane, can be described using solvatochromic analysis 
(Abraham et al., 1994; Abraham et al., 1999b). This is achieved by factorising the partition 
coefficient into steric and polar terms which describe various intermolecular interactions as 
expressed by Eq. (1.9) (Giaginis and Tsantili-Kakoulidou, 2008): 
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ceEsSbBaAVP  100/log                  (1.9) 
where V is the McGowan’s characteristic molar volume, A and B are the solute’s hydrogen-
bonding acidity and basicity, respectively, S is a combined dipolarity/polarisability term 
reflecting the solute’s capacity to elicit orientation and induction forces, E is the excess molar 
refractivity. υ, a, b, s, e, c are constants derived by multiple linear regression analysis describing 
characteristics of the systems (Abraham and McGowan, 1987). 
 
1.2. Biological relevance of lipophilicity 
 
Lipophilicity is one of the most fundamental physicochemical properties influencing 
the biological activity of drugs. Lipophilicity dictates the absorption, distribution, metabolism 
and excretion of drugs and a key factor in the formulation of pharmaceuticals. Furthermore, 
the affinity of compounds towards lipophilic environments within biological systems helps in 
transporting them across membranes to the target sites where they illicit their biological effects 
(Rutkowska et al., 2013).  
 
It is widely accepted that lipophilicity, solubility and ionisation are the key 
physicochemical parameters in the predictability of a drug’s bioavailability, and significantly 
influences a drug’s pharmacokinetic, pharmacodynamic and toxicological behavior (Wang and 
Skolnik, 2009; Van De Waterbeemd, 2009). This is exemplified by the fact that 
physicochemical properties are required for quantitative modeling of in vitro and in vivo 
biological data. Such physicochemical properties have proved to be useful in predicting drug 
permeation across biological membranes and barriers, for example skin, intestinal mucosa and 
the blood-brain-barrier (Kubinyi, 1995; Pagliara et al., 1999; Cross et al., 2003; Wang and 
Skolnik, 2009). For a variety of reasons, the oral route of drug delivery is the most desirable, 
therefore, much research has focused on optimising the absorption and bioavailability of drugs 
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following the oral route (Waterbeemd and Testa, 2009). Following on from absorption, 
lipophilic molecules can easily pass through the cell membrane (intercellular pathway) or 
cytoplasm (intracellular pathway) to reach the blood stream and from there the target site. 
Ionisation of drug molecules, along with many other factors, may limit absorption (Rutkowska 
et al., 2013) which can be an issue. The intestinal absorption of drugs has been studied through 
various in vitro techniques, for example, the Caco-2 cell line system (Hildago et al., 1989) and 
the physicochemical parallel artificial membrane permeability assay (PAMPA) (Kansy et al., 
1998; Avdeef et al., 2007) which have remained the most popular approaches for estimating 
intestinal absorption. Although these models are mechanistic in nature their applicability has 
been questioned owing to the poor predictability found for some drugs (Verma et al., 2007).  
 
Waterhouse (2003) demonstrated a relationship between a drug’s lipophilicity and 
blood-brain-barrier permeation and explained situations in which lipophilicity could be a good 
predictor and an under-predictor, for example if the compound was highly lipophilic. These 
results were consistent with those published by Hansch and co-workers (1987) explaining 
reduced blood-brain-barrier uptake of highly lipophilic drugs as a consequence of non-specific 
plasma protein binding and a high uptake for moderately lipophilic drugs.  
 
Correlating lipophilicity with skin permeability has remained an area of great interest 
in recent years and various mathematical models have been proposed for predicting skin 
permeability (Potts and Guy, 1992; Barratt, 1995; Potts and Guy, 1995; Abraham et al., 1995; 
Abraham et al., 1999a; Moss et al., 2002; Yamashita and Hashida, 2003). Despite its ability to 
correlate some biological properties, lipophilicity has been questioned several times, for 
example, isotropic organic-water partition coefficients have failed to encode some important 
recognition forces in biochemistry and molecular pharmacology, most notably ionic bonds, 
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which are important in modeling interactions of ionised species with biomembranes (Hartmann 
and Schmitt, 2004; Liu et al., 2011). 
 
However, in general, lipophilicity is an established property that influences the 
distribution of drugs through drug-plasma protein interactions, consequently influencing 
pharmacokinetic and pharmacodynamic behaviour (Zoghbi et al., 2012). For example, the 
influence of lipophilicity on tissue distribution kinetics for some basic drugs has been reported 
by Yokogawa and co-workers (2002). Their study revealed that the uptake of basic drugs into 
lysosomes depended on both intra-lysosomal pH and drug lipophilicity, thus, a linear 
correlation was found between lipophilicity and lysosomal drug aggregation (Yokogawa et al., 
2002). This relationship was further confirmed by Lazicek and Laznickova (1995) who 
described that the binding of some anionic drugs with plasma proteins and blood cells was 
dependent on drug lipophilicity.  
 
A compound, after being absorbed and distributed in the body, is subjected to 
metabolism or biotransformation prior to elimination from the body. This usually occurs in two 
phases, namely phase I and phase II metabolism. The phase I metabolism pathway includes 
oxidation, reduction and hydrolysis. As a result of phase I metabolism, compounds are 
modified by the introduction of polar groups which reduce lipophilicity, thus facilitates 
elimination. In phase II, drugs are conjugated with charged species, namely glutathione, 
glycine or glucuronic acid resulting in formation of a less active complex. This complex often 
has a higher molecular weight with an associated impact on lipophilicity which restricts its 
diffusion across membranes and is therefore actively transported out of the body through renal 
and bile excretion (Rutkowska et al., 2013). 
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As long ago as the 19th century, it was established that lipophilicity may affect the 
toxicological properties of compounds, for example, it has been shown to be influential in 
cytotoxic studies performed on heart muscles (Halbach, 1990). Similarly, the toxicity of local 
anesthetics can be substantially increased at logP values above 3.0 because of a high plasma 
availability of these compounds and enhanced absorption into the blood-brain barrier (Nava-
Ocampo and Bello-Ramírez, 2004). For all these reasons it is important to be aware of the 
lipophilicity of a compound and this is why it must always be determined for new chemical 
entities. 
 
1.3. Octanol-water partition coefficients (logPOW) 
 
The octanol-water system holds the ‘gold standard’ as a widely accepted reference 
system for describing the lipophilicity of compounds. Octanol offers some advantages over 
other organic solvents, namely the presence of hydrophobic chains with a polar head group, 
which correlates well with biological activity (Danielsson and Zhang, 1996; Giaginis and 
Tsantili-Kakoulidou, 2008). It also correlates well with soil sorption constants, water solubility 
and other parameters that are key in predicting biochemical and toxicological effects (Cairns 
et al., 1979). The hydroxyl group in the n-octanol molecule has a hydrogen bonding capability 
both as a donor and an acceptor, similar to a membrane, and a receptor’s hydrogen bond 
property. As biological membrane properties differ somewhat from the octanol-water system, 
some alternatives have been proposed to imitate different physiological membranes, for 
example, chloroform-water, dibutylether-water and propylene glycol diperlagonate-water 
systems. In biological systems with no hydrogen bond donor or acceptor group available on 
the membrane, an alkane-water system or dichloroethane-water system would be preferable 
(Leahy et al., 1989; Avdeef et al., 1996; Hartmann and Schmitt, 2004). Although the 
amphiphilic properties of octanol partially resemble conditions for the biopartitioning of 
 
10 
compounds having moderate lipophilicity or hydrophilicity, the octanol-water system does not 
reflect biological partitioning (Rutkowska et al., 2013) for highly lipophilic or hydrophilic 
species which is why various alternative systems are under development. 
 
1.4. Methods to measure partitioning 
 
Numerous methods have been proposed to estimate partition coefficients for 
compounds including the previously discussed octanol-water system, reverse phase 
chromatography, micellar and microemulsion electrokinetics, liposome-water systems and 
computational systems using a fragmental approach. A brief summary of all these methods 
alongside some advantages and drawbacks is summarised in Table 1.1. 
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Table 1.1: Methods to determine or estimate the partition (Kah and Brown, 2008) 
Method Advantage Drawback Not applicable if References 
Direct 
Shake-flask Widely used method, 
reliable 
Time, quantity of 
product used, formation 
of octanol emulsions in 
water 
logP > 6; the tested substance 
dissociates (POW depends on 
concentration) 
(OECD, 1995) 
Slow stirring method Avoids the formation 
of emulsions, reliable 
Time, quantity of 
product used 
The tested substance dissociates (POW 
depends on concentration) 
(Brooke et al., 1986; 
De Bruijn et al., 1989) 
Chromatographic methods 
Classical chromatographic 
approach 
RP-TLC and RP-HPLC 
Rapid and cheap, does 
not require chemical 
quantification 
Different retention 
mechanisms; poor 
reproducibility; pH 
range limited to 2-7.5 
Very low POW values (Sicbaldi and Finizio, 
1993; Finizio et al., 
1997; OECD, 2004) 
Counter-current (CCC) and 
Immobilised artificial 
membrane (IAM) 
chromatography 
Versatile and reliable 
method 
CCC has low accuracy 
and resolution. 
IAM is costly and short 
life time of column 
IAM is not applicable if volume phase 
ratio changes 
(Berthod et al., 2009; 
Hartmann and Schmitt, 
2004) 
Micellar and 
microemulsion 
electrokinetic 
chromatography 
Rapid and cheap Requires the 
establishment of 
solvation parameter 
model 
Ionic substance (Poole and Poole, 
2003) 
Others 
Filter probe method Rapid; well adapted 
to construct a 
logD/pH profile 
Expensive equipment 
required, slow to set up 
logP < 0.2; no isosbestic point (Takács-Novák et al., 
1995; Leo, 2000) 
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Table 1.1: Continued…. 
Method Advantage Drawback Not applicable if References 
pH metric method (or 
potentiometric method) 
Rapid; well adapted 
to construct a 
logD/pH profile 
Expensive equipment 
required 
Insoluble compound (Chamberlain et al., 
1996; Avdeef, 2001) 
Calculation 
Regressions with other 
properties 
Quick and cheap Result depends on the 
dataset 
  (Xing and Glen, 2002; 
Lü et al., 2007) 
Computational method 
(fragmental approach) 
Wide range of 
chemicals; reliable for 
neutral compounds; 
only reliable method 
for POW > 5 
Not reliable for 
zwitterionic, 
tautomeric, charged 
compounds and 
strongly hydrogen-
bonding compounds 
Fragment not available in the software 
database 
(Leo, 2000; Mannhold 
and Van De 
Waterbeemd, 2001; 
Machatha and 
Yalkowsky, 2005)  
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1.4.1. Direct measurement methods 
 
The shake-flask method remains the most widely used experimental protocol utilising 
an octanol-water system and it has been designated as the standard method in the Organisation 
of Economic Cooperation and Development (OECD) guidelines for determining partition 
coefficients (OECD, 1995; Danielsson and Zhang, 1996). In the shake-flask method, a test 
substance is spiked in the octanol-water system in a separating funnel and shaken for 24 to 72 
hours to attain an equilibrium as shown in Figure 1.1. The octanol and water phases are then 
separated and the concentration of substance in each layer is determined using standard analysis 
procedures involving either UV-spectrophotometry or high performance liquid 
chromatography (HPLC). From the ratio of a compound’s concentration in each layer, the 
partition coefficient can be calculated using Eq. (1.1). The shake-flask method is a laborious 
and time consuming process that requires a very high purity of compound in relatively large 
amounts. Furthermore, it is only suitable over a narrow range of partition coefficient values i.e. 
-3 to +3 which limits its applicability. Glass and surface adsorption is another limitation that 
must be minimised to attain reliable results (Danielsson and Zhang, 1996). Furthermore, the 
aqueous phase often requires centrifugation after equilibration in order to remove the small 
droplets of octanol in the form of an emulsion created during shaking (Leo et al., 1971). 
Although, it may be possible to remove the emulsion that was formed during shaking, 
discrepancies occur in the values obtained (Hansch and Leo, 1979; Finizio et al., 1997). 
Furthermore, dissociation of molecules into the ionised form may also influence the partition 
coefficient, thus, this method is only applicable to compounds that are non-ionised (OECD, 
1995). 
 
Alongside the shake-flask method is the slow-stir method which follows similar 
principles but mixing is achieved at a very slow stirring speed in order to avoid the formation 
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of an emulsion which can hinder the measurement of true partition coefficients (Brooke et al., 
1986; De Bruijn et al., 1989).  
 
In summary, both methods are time consuming and expensive (in terms of high amount 
of compound requirement), and applicable to only neutral compounds or ionisable compounds 
in their neutral form, thus limiting their suitability and versatility. 
 
1.4.2. Chromatographic methods 
 
Various chromatographic approaches have been proposed to determine partition 
coefficients. One such approach is thin layer chromatography (TLC) which allows 
determination of lipophilicity in a relatively simple and fast way without utilising expensive 
equipment (Biagi et al., 1975; Biagi et al., 1992). Essentilally, a compound is bound either 
covalently or by adsorption on a solid surface usually made of silica. This solid surface (or 
TLC plate) is then introduced to a mobile phase and movement of compound on the plate is 
recorded. The lipophilicty descriptor, namely retardation factor RM is calculated from the 
retention factor, Rf as described in Eq. (1.10): 
)
1
1log(  fM RR                  (1.10) 
where Rf is calculated on the basis of migration distances of a compound and the solvent front. 
The chromatographic parameter R0M for pure water is obtained by extrapolating the linear 
relationship of RM and various concentrations of organic modifier in the mobile phase as given 
in Eq. (1.11): 
 SRR MM 0                  (1.11) 
where S is the slope of the linear plot and ϕ is the concentration of organic modifier.  
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Although TLC based logP determination overcomes some of the difficulties associated 
with the shake-flask method, results may be non-reproducible owing to the effects of the 
gradiant of the mobile phase on the surface of the TLC plate (Giaginis and Tsantili-Kakoulidou, 
2008). 
 
The reverse phase-HPLC appraoch (OECD, 2004) utilises a stationary phase packed 
inside a column with a mobile phase that runs through the stationary phase, thus, retainig 
compounds onto the stationary phase which is then used to decribe the lipophilicity. There is 
no chemical quantification required in this method, therefore, it is seen as a fast and cheap 
method (Kah and Brown, 2008). A number of studies have been published which describe the 
HPLC method for determination of octanol-water partition coefficients (Könemann et al., 
1979; Garst and Wilson, 1984; Braumann, 1986; De Kock and Lord, 1987). The method 
encompasses the establishment of correleations between retention data (in terms of capacity 
factor of compounds of interest) and the known octanol-water partition coefficients of 
structurally similar compounds.  It would not be wrong to say that this method is restricted to 
a homologous series of compounds and discrepencies often arise when suitable standards are 
unavailable. Another drawback is the narrow range of pH (usually from 3-7.5) for silica based 
columns to remain stable, therefore, this limits its suitability for ionic compounds (Danielsson 
and Zhang, 1996). 
 
In addition to the above mentioned chromatographic methods, counter-current 
chromatography (CCC) and immobilised-artificial membrane (IAM) chromatographic 
approaches have been proposed as alternatives to the shake-flask method for measurement of  
partition coeffcients. Counter-current chromatographic determination of logPOW is attractive 
because it utilises a liquid stationary phase instead of a solid stationary phase which allows 
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partitioning of compounds between two immiscible liquids. For example, this technique has 
been successfully applied to a series of 23 ionisable compounds with a high correlation with 
experimental and computational logP values (Berthod et al., 1999), however, in a more recent 
study, a poor correlation was demonstrated (Carda-Broch and Berthod, 2003).  
 
IAM chromatography utilises a stationary phase that is prepared from phospholipids 
covalently bonded to a propylaminosilica support material at monolayer densities, thus, mimics 
the lipid biomembrane on a solid surface (Taillardat-Bertschinger et al., 2003). IAM columns 
permit the use of an aqueous mobile phase without any addition of organic modifier which 
allows a direct measurement of logP values. Since the artificial membrane provides a closer 
mimic to the amphiphilic microenvironment of biomembranes ionic interactions are likely to 
be present which potentially makes it a superior technique (Taillardat-Bertschinger et al., 
2003). Using this technique, lipophilicity is expressed as the retention capacity on an IAM 
column under isocratic conditions, assuming that the molar volume ratio of stationary and 
mobile phase does not vary from column to column (Hartmann and Schmitt, 2004; Valko, 
2004). The lipophilicity scale of IAM chromatography has shown a good correlation with 
passive transport from the small intestine of rats, thus, endorsing its reliability as a predicitor 
of lipophilicty (Genty et al., 2000). However, there are disadvantages, for example IAM 
columns tend to have shorter life-times due to the leaching of phosphoilipids (Taillardat-
Bertschinger et al., 2003) and they are an expensive system to study, even for partitioning of 
compounds.  
 
Micellar electrokinetic chromatographic (MEKC) and microemulsion electrokinetic 
chromatographic (MEEKC) approaches have been investigated for the estimation of partition 
coefficients (Herbert and Dorsey, 1995; Örnskov et al., 2005). Micellar electrokinetic 
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chromatography utilises a correlation between the partitioning of compounds in a micellar 
system (surfactant above its critical micellar concentration that forms an aggregate called a 
micelle) and the octanol-water partition coefficient through a linear solvation energy 
relationship (Hartmann and Schmitt, 2004). The retention factor in MEKC is derived from the 
migration time of solute of interest, an unretained solute and the micelle under electric current, 
thus, capacity factors are directly related to the solute’s partitioning between the micelle and 
water.  
 
It has been proposed to use small oil droplets in the micrometer size range instead of 
surfactant micelles to more closely mimic phospholipidic membranes (Örnskov et al., 2005). 
This technique has been named as microemulsion electrokinetic chromatography (MEEKC) 
which allows determination of partition coefficients in the log range of 0 to 5 for weakly acidic, 
basic or neutral compounds after ion supression (Poole and Poole, 2003; Henchoz et al., 2010). 
However, results may not correlate well with logD values in the case of ionisable compounds 
(Poole and Poole, 2003). 
 
1.4.3. Further methods to measure partitioning 
 
In addition to the methods discussed above, several others are known including pH 
metric and filter probe methodologies (Chamberlain et al., 1996; Avdeef, 2001). These 
methods require expensive equipment and are not yet approved by the OECD.   
 
Theoretical and computational methods have also been proposed to obtain logP values. 
There are at least 20 software systems avaiable that have the capability to generate lipophilicity 
parameters from the structural fragments of a compound. Although results are fairly consistent 
with the direct measurement methods, discrepencies are observed in the case of compounds 
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that have interacting functional groups or complex functional groups that are not avaialable in 
the software database (Finizio et al., 1997). A few examples of commonly used computational 
tools are discussed below; 
a. AlogPs  
 
  This method, for the assessment of octanol-water partition coefficients, was developed 
on the basis of neutral network ensemble analysis of 12908 organic compounds. The atom and 
bond-type E-state indices and the number of hydrogen and non-hydrogen atoms were 
considered in calculations. A first selection of indices was performed by multiple linear 
regression analysis, and 75 input parameters were selected. Some of the parameters combined 
several atom-type or bond-type indices with similar physicochemical properties (Tetko et al., 
2005; Tetko and Tanchuk, 2002). 
b. IAlogP  
 
This method is based on the set of 238 MolconnZ molecular indices generated from 
13000 organic structures with accurately measured logP values. Interactive Analysis, using 
neutral networks technology to derive a set of 10 fold cross-validated networks, developed the 
IAlogP predictor (Tetko et al., 2005).  
c. clogP  
 
This method estimates interaction parameters for new fragments; clogP is based on an 
estimation of these interactions on the well-accepted principles defined by Hammett. Not only 
is clogP the most accurate calculation available but it produces results that are based on 
established chemical interactions, unlike other programs which are based solely on statistics 
(Ghose et al., 1998). 
d. logPKowwin  
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This is an atom-fragment contribution method for octanol-water logP calculation. 
This method logPKowwin is based on data for 13058 organic compounds, for which accurate 
experimental partition coefficients logP are published (Meylan and Howard, 1995). 
e. xlogP   
 
This is an atom-additive method for octanol-water logP calculation. A large dataset of 
1831 organic compounds was analysed by multivariate regression to derive the parameters. 
This method includes correction factors to account for intramolecular interactions. After 
including these correction factors, the final logP is described as:  
j
jj
i
ii BbAaPlog                 (1.12) 
where a i and bj are regression coefficients, Ai is the number of occurrences of the ith atom type, 
and Bj is the number of occurrences of the jth correction factor identified by this program 
(Wang et al., 1997). 
f. miLogP   
 
This method for logP prediction, developed at Molinspiration (miLogP 2.2), is based 
on group contributions obtained by fitting calculated logP values with experimental logP values 
for a training set of more than twelve thousand, mostly drug-like molecules (Rutkowska et al., 
2013). 
 
1.5. Micellar liquid chromatography 
MLC is a form of high pressure liquid chromatography in which the mobile phase is 
composed of a micellar solution which is non-toxic to the environment i.e. preferential to 
conventional organic solvents. Aqueous solutions of surfactants above their critical micelle 
concentration (CMC) have the ability to arrange themselves into a well organised spherical 
aggregate known as a micelle. Generally, the outer surface of a micelle is hydrophilic while 
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the inner core of a micelle favours hydrophobic compounds. This kind of arrangement of 
surfactants in an aqueous solution allows them to be a highly effective mobile phase for 
micellar liquid chromatography (García Diez et al., 2004). Micelles provide a heterogeneous 
environment to solutes, therefore, solutes may experience different microenvironment 
polarities in a given micellar mobile phase (Khaledi and Breyer, 1989).  
Like reverse phase high performance liquid chromatography (RP-HPLC), MLC utilises 
a non-polar stationary phase which is often a hydrocarbon chain and a polar liquid mobile phase 
to separate the compounds. MLC instrumentation is rather simple and identical to that of the 
RP-HPLC including an isocratic pump, an injector, a stationary phase column and a detector 
with the only difference being in the nature of the mobile phase. In RP-HPLC, mobile phases 
are usually composed of a mixture of water and an organic solvent, such as methanol or 
acetonitrile. Generally, when an analyte is injected into an HPLC, it partitions out of the mobile 
phase and interacts with the stationary phase (depending upon its polarity and hydrophobicity). 
This interaction leads to the retention of analyte on the stationary phase. If a compound is very 
polar, it will not significantly interact with the stationary phase, yet with a decrease in polarity, 
the residence time of analyte will increase in the column resulting in higher retention times 
(Meyer, 2010). MLC offers the introduction of micelles to the mobile phase without the 
addition of an organic solvent, thus, it permits the partitioning of an analyte between the 
micelle, an aqueous phase and the stationary phase to be determined. In addition to this, the 
presence of micelles maintains the solubility of nonpolar and hydrophobic solutes. 
Furthermore, without the addition of toxic organic solvents, MLC is a more environmental 
friendly and a low cost analytical technique compared with other systems. 
Since the first report, MLC has been in constant development (Mutelet et al., 2003) and 
several research groups have explored different aspects of MLC, for example, separation of 
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mixture of solutes (Mao et al., 2004; Safa and Hadjmohammadi, 2005), separation of 
enantiomers (Gübitz and Schmid, 2006) and analysis of pharmaceutical compounds in 
formulations (Kulikov and Verushkin, 2008; Zhao et al., 2013). 
1.5.1. Surfactants and micellisation 
 
In MLC surfactant solutions above a specific concentration (where micelle formation 
occurs) are used as the mobile phase. Surfactants belong to a class of chemicals known as 
amphiphiles which means these compounds have a hydrophilic head group and a hydrophobic 
tail (Texter, 1999). The term ‘surfactant’ is a short form of ‘surface active agents’ which means 
any material, when used in low concentration, that is adsorbed onto the surface or at the 
interface of a system leading to an alteration in the interfacial free energies of the interface.  
The term ‘interface’ means a boundary between two immiscible systems or phases. The 
interfacial free energy refers to the minimum amount of work required to create that interface 
(Rosen and Kunjappu, 2012). When a surfactant molecule is dissolved in water, the 
hydrophobic part of the surfactant may alter the structure of water (by breaking the hydrogen 
bonding), thereby, rearranging the water molecules in the vicinity of the hydrophobic part and 
increasing the free surface energy of the solution. As a result, the system responds in a way to 
minimise the contact between the hydrophobic part and the water. Therefore, some of the 
surfactant molecules are expelled to the surface where the hydrophobic part is predominantly 
oriented towards the air (since air molecules are nonpolar, there is no dissimilarity between 
these two phases) so as to minimise the contact with the water molecules. On the other hand, 
the hydrophilic head group prevents the surfactants from being expelled from the water phase, 
thus, the hydrophilic group stays inside the water phase. In this way a concentrated monolayer 
of surfactant is developed at the interface which minimises the surface tension of water (Rosen, 
2004a).   
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Surfactants are generally classified by the charge of the hydrophobic head group i.e. 
anionic, cationic, nonionic, and amphoteric or zwitterionic. The anionic surfactants are most 
commonly used because of their low cost and commercial availability in high purity. An 
anionic surfactant dissociates in aqueous solutions to give a negatively charged surface active 
portion and an inactive cation, commonly Na+ or K+. The four main families of anionic 
surfactants are soaps, sulfonated compounds, alkylsulfates and alkylphosphates. Sodium 
dodecyl sulfate (SDS), which is an anionic surfactant from the alkylsulfate class, is the most 
widely used surfactant in MLC. Cationic surfactants are those that dissociate into a cationic 
amphiphile and an inactive anion, commonly Cl- or Br-. The most common cationic surfactants 
used in MLC contain a quaternary ammonium group, such as cetyl trimethylammonium 
bromide (CTAB). Nonionic surfactants have a polar group such as an ether, alcohol, carbonyl 
or amino group as their hydrophilic portion. Zwitterionic surfactants contain both positive and 
negative charges on the same molecule (Berthod and Garcia-Alvarez-Coque, 2000). 
 
Surfactants and their physicochemical properties have been extensively studied over 
the years. It was firmly accepted from the very beginning that surfactants possess unusual bulk 
properties and indicated the presence of colloidal ions in surfactant solutions (Rosen, 2004b). 
The concept of ‘colloidal ions’ was given by James William McBain and co-workers to explain 
the conductive properties of sodium palmitic solutions (McBain et al., 1912). Later in 1936, 
the term ‘micelle’ was introduced and promoted for colloidal ions by G. S. Hartley in his book 
‘Aqueous Solutions of Paraffin-Chain Salts, A Study in Micelle Formation’ (Hartley, 1936).  
 
With the increase in surfactant concentration in solutions, the interface becomes more 
and more saturated with monomers, resulting in a substantial decrease in the interfacial tension 
and surface free energy. Further addition of surfactants abruptly changes the physicochemical 
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properties of the solution and the formation of micelle occurs. There is no definite 
concentration of surfactant at which spontaneous micellisation occurs, in fact, micelles exist 
above a narrow concentration range known as the critical micelle concentration (CMC). It 
should be noted that the formation of a micelle itself is a process of minimising the free energy 
of the solution. Therefore, micellisation is an alternative mechanism to surface adsorption of 
surfactants in order to reduce the contact with the water and a way of reducing the free energy 
of a system through micelle formation. It is noteworthy that the process of micellisation is 
predominantly observed in aqueous media because of the surfactant’s ability to distort the water 
molecules. Therefore, micelles of size comparable to those formed in aqueous media are 
seldom observed in the non-aqueous solvents where surfactants have little chance of distorting 
the structure of the solvent or the surfactants have a very short hydrophobic tail if water is the 
solvent (Rosen, 2004b). 
 
Micelles exist in dynamic equilibrium with monomers in solution. The structure of a 
micelle is dependent on the concentration of monomers in the solution. At a concentration 
equal to, or above, the CMC, the monomers tend to aggregate to acquire a spherical shape with 
the tail groups oriented inside the core and the head groups oriented outward facing i.e. towards 
the aqueous media. Generally, a certain number of monomers aggregate to form a micelle 
known as the aggregation number (AN). Different surfactants have different CMCs and ANs 
depending upon their physicochemical properties. Almost all surfactants will form spherical 
micelles at a concentration close to the CMC, however, ionic surfactants at higher 
concentrations will transform into elongated cylindrical, rod like, large lamellar and vesicular 
structures as shown in Figure 1.1. In the case of non-ionic surfactants, spherical micelles 
directly change into lamellar structures at higher concentrations (Moroi, 1992).  
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Figure 1.1: Transformation of micelles into different shapes on increasing surfactant 
concentration (Moroi, 1992) 
 
Thermodynamically, micelle formation follows a pseudo-phase equilibria owing to 
their dynamic nature. The term ‘dynamic’ is used for micelles because micelles exist in a 
thermodynamic equilibrium i.e. there is a constant and very rapid interchange of surfactant 
monomers within a micelle, as well as the fact that micelles are continuously falling apart and 
new micelles are formed from a different set of monomers. The average lifetime of an 
individual micelle is approximately 10-3 to 1 second, while exchange of monomers in an 
existing micelle occurs within 10-8 to 10-4 seconds (Berthod and Garcia-Alvarez-Coque, 2000). 
The process of micellisation depends upon various interactions between: 1) the hydrophobic 
tail group and water, 2) hydrophobic interactions of the tail group with adjacent tail groups 
within the micellar core, 3) surfactant head groups with each other and 4) solvation of the head 
group in water (Berthod and Garcia-Alvarez-Coque, 2000; Eastoe, 2009). Based on these 
interactions, micellisation can be expressed mathematically as: 
ANSSAN                   (1.13) 
and 
ANSmSSAN                   (1.14) 
 
where AN is the aggregation number, S is the concentration of given surfactant associating to  
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form a micelle, m is the number of free surfactant monomers, and SAN is the micelle comprised 
of S monomers. When the surfactant monomers and micelles attain equilibrium, the 
equilibrium constant (Keq) can be expressed as: 
   ANANeq SSK                    (1.15) 
The change in the standard Gibb’s free energy (ΔG) of micelle formation can be expressed as: ∆ܩ = −ܴܶ ݈݊���                 (1.16) 
Where R is the gas constant and T is temperature in Kelvin. Equation 1.16 can be written as: 
SRTS
AN
RT
AN
G
AN lnln                                       (1.17) 
 
For micelles formed of sufficiently large aggregation number (AN), typically greater 
than 50, the first term on the right hand side of the equation can be neglected. Since S is the 
concentration of monomers to form a micelle, the above equation can be written in terms of 
CMC:  
CMCRTG ln
                 (1.18)  
 
The resultant ΔG of micellisation calculated from Eq. (1.18) will be negative implying 
that the micellisation is a spontaneous exothermic process. The change in entropy (ΔS) can 
then be expressed as: 
dT
CMCdRTCMCR
dT
GdS )(lnln)( 
                         (1.19) 
Knowledge of the CMC for a given surfactant is critical to ensure optimal experimental 
conditions. There are various factors that influence the CMC in aqueous solutions including 
hydrophilic and hydrophobic groups, counter ion effects (in the case of ionic surfactants), 
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electrolytic effects of added salts (ionic strength), effect of added organic solvents, effect of 
added solutes and temperature effects. Determination of the CMC has remained an area of great 
interest over the decades and various methods have been devised for the measurement of CMC 
including surface tension, conductivity, osmotic pressure, turbidity, dye absorbance and more 
recently isothermal titration calorimetry which is more accurate and sensitive than the former 
techniques (Berthod and Garcia-Alvarez-Coque, 2000; Waters et al., 2012a).  
 
1.5.2. Stationary phase and surfactant adsorption in MLC 
 
Liquid chromatographic columns are typically composed of silica based packing 
bonded with an R group to create a specific column chemistry. The silica particles are 
derivatised with chloro-silanes containing certain groups (alkyl, phenyl and cyanopropyl) that 
react with the surface hydroxyl groups (Si-OH) known as silanols. After binding of these 
groups to the silica surface, many silanols are left unreacted known as residual silanols. The 
residual silanols can have a pKa range of 4-9.8 depending upon the silica used (Berthod, 1991). 
   
Surfactant adsorption on the stationary phase has a dramatic effect on the retention 
behavior of solutes resulting in changes in the surface properties of the stationary phase. 
Surfactant monomers coat the stationary phase pores, thus minimising the silanophilic 
interactions. The amount of adsorbed surfactant increased in the order: bare silica 
<cyanopropyl<methyl<octyl<ocadecyl, which agrees with the decreasing stationary phase 
(Ruiz-Ángel et al., 2009). Surfactant interactions with the stationary phase have been 
extensively studied and determined as surfactant monomers tend to adsorb onto the stationary 
phase. Lavine and coworkers examined the surfactant interactions with different silica 
modified stationary phases, namely cyanopropyl, C18 and C8.
 
They found that the hydrophobic 
alkyl tail of SDS was associated with the bonded layer of the C8 and C18 stationary phases, 
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while the sulfate polar group of SDS protrudes out of the bonded layer (Lavine et al., 1994). 
Conversely, the polar head group of CTAB is incorporated within the bonded phase, with the 
tail group oriented outward. For the cyano-bonded phase (Figure 1.2), both the CTAB and SDS 
surfactants became tightly bound and entwined within the bonded phase through electrostatic 
interactions (Lavine et al., 1996). 
 
 
 
Figure 1.2: Solute environment in a chromatographic system using octadecyl-bonded (a & 
b) and cyanopropyl-bonded phases (c & d) with anionic SDS (a & c) and cationic CTAB (b 
& d) (Ruiz-Ángel et al., 2009) 
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1.5.3. Interaction of solute with micelle and stationary phase 
 
The retention behaviour of compounds can be explained by the interactions between 
the solutes, the surfactant- modified stationary phase and the micelle. It has been reported that 
neutral solutes eluted with non-ionic and ionic surfactants, and charged solutes eluted with non-
ionic surfactants will only be affected by non-polar, dipole-dipole and proton donor-acceptor 
interactions. However, charged solutes will interact electrostatically with ionic surfactants. 
Also, the steric effect can be an important parameter in such solute/surfactant interactions 
(Marina et al., 1996; Ruiz-Ángel et al., 2009). 
 
In the case of electrostatic attractions, charged solutes can be strongly retained in MLC 
giving rise to a combination of attraction and hydrophobic interactions. Conversely, charged 
solutes cannot be retained by the stationary phase owing to electrostatic repulsion and elute at 
the dead volume, unless significant hydrophobic interactions with the modified stationary 
phase exist. 
 
For most solutes, retention times decrease with increasing the surfactant concentration 
in MLC. However, those which interact sufficiently with the micelle, elution strength increases 
with increasing surfactant concentration. According to their elution behaviour with a micellar 
mobile phase, solutes have been classified into three categories: solutes binding to the micelle, 
non-binding and anti-binding solutes (Armstrong and Stine, 1983). Solutes that bind to micelles 
show decreased retention with increasing surfactant concentration in the mobile phase, 
whereas, for solutes having no interaction or binding with micelle (non-binding), the retention 
remains unaltered with respect to surfactant concentration. A less common interaction, namely 
anti-binding causes an increase in retention with increasing surfactant content in the micellar 
mobile phase. Electrostatic repulsion is an important issue in anti-binding behaviour, since anti-
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binding solutes with anionic or cationic surfactants are negatively or positively charged, 
respectively. However, positively charged compounds eluted with a cationic surfactant and a 
negatively charged compound with an anionic surfactant may exhibit binding behaviour owing 
to hydrophobic interactions (Ruiz-Ángel et al., 2009). 
Since ionic surfactants tend to adsorb on the C8 or C18 bonded phases (Figure 1.2a & 
b), the negatively charged layer for SDS and positively charged for CTAB, will elute at the 
dead volume owing to electrostatic repulsions. On the contrary, when using C1 or cyano-
bonded phases (Figure 1.2c & d), which do not adsorb a large amount of surfactants, the anti-
binding behaviour is observed.  This could be a consequence of a compound being strongly 
excluded or repelled from the micelle, which forces the solute onto the stationary phase, where 
it is retained due to hydrophobic interactions. Armstrong and Stine studied the effect of ionic 
strength and behaviour of solutes from anti-binding to binding behaviour with a small change 
in the micellar environment which proved the electrostatic nature of the implied interactions 
(Armstrong and Stine, 1983). However, it seems that for the transition from anti-binding to 
binding, the hydrophobicity of the charged solute must be sufficiently high to associate with 
the non-polar portion of the micelle, once electrostatic repulsion has been minimised by salt 
addition (Ruiz-Ángel et al., 2009).  
 
1.5.4. Armstrong’s partitioning model 
The partitioning process of compounds in MLC is much more complicated than that for 
HPLC because of the presence of three types of equilibria (Armstrong and Nome, 1981) i.e. 
between the stationary phase and water (PSW), between the micelles and water (PMW), and 
between micelles and the stationary phase (PSM) as illustrated in Figure 1.3. 
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Figure 1.3: Three phase equilibria in micellar liquid chromatography; adapted from 
Armstrong and Nome (1981) 
 
 
Armstrong and Nome (1981) derived the partition coefficients from the relationship of 
the capacity factor (k’) with the concentration of micelles in the mobile phase. The capacity 
factor is derived from the retention times of solute (tr) and the dead time (t0) as expressed in 
Eq. (1.20):  
k′ = �ೝ−�0�0                                                                                  (1.20) 
On the basis of three phase equilibria, Armstrong and Nome (Armstrong and Nome, 
1981) proposed an equation which can possibly calculate micelle-water partition coefficients 
for solutes as expressed in Eq. (1.21): 
ଵk′ = [�ሺ୔MW−ଵሻ�×୔SW ] × CM + ଵ�×୔SW                               (1.21)          
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where, k’ is the capacity factor of solute, � is the molar volume of the surfactant, PMW   is the 
partition coefficient of solute between micelle and water, � is the phase volume ratio 
(stationary phase volume/mobile phase volume), CM is the micellar concentration of the 
surfactant (total surfactant concentration minus critical micellar concentration), and PSW is the 
partition coefficient between water and stationary phase.  
Unlike Armstrong and Nome, Arunyanart and Cline Love (Arunyanart and Cline Love, 
1985) explained the three phase equilibria in terms of following equations: 
(1) Association of the solute (A) in the bulk aqueous phase with the micelle: 
 � + � ⇋ AM ≈ ��� = [��][�][�]                                   (1.22) 
(2) Association of the solute in the bulk aqueous phase with the stationary phase: 
           � + ܵ ⇋ �ܵ  ≈ �ௌ� = [�ௌ][�]+[ௌ]                                                                     (1.23) 
(3) Direct transfer of solute in the micelle to stationary phase: 
         �� + ܵ ⇋ �ܵ + � ≈ �ௌ� = [�ௌ]+[�}[��]+[ௌ]                                                         (1.24)                                              
The magnitude of solute retention expressed as the capacity factor (k’) is defined as 
(Arunyanart and Cline Love, 1985): 
݇′ = � [�ௌ][�]+[��]                                                                                                                    (1.25) 
Substituting equilibrium constants (PAM and PSW) in the Equation (1.25) gives: 
݇′ = �×���ଵ+���[��]                                                                                                               (1.26) 
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On taking inverse of the Eq. (1.26) and then rearranging it: 
ଵ�′ = ����×��� [��] + ଵ�×���                                                                                            (1.27) 
Since molar volume of surfactant (v) remains constant with respect to surfactant concentration 
and can be neglected from Equation (1.21), which gives a similar expression as given by 
Equation (1.27). Experimental values for k’ obtained at various surfactant concentrations can 
be used to plot a graph of 1/k’ and CM. From this linear relationship the ratio of the slope and 
intercept represents PMW, while PSW is calculated from the intercept. Furthermore, if PMW and 
PSW are known, the partition coefficient between stationary phase and micelle can be calculated 
using the relationship given in Eq. (1.28): 
PSM = ୔SW୔MW                  (1.28) 
The combined effects of these three equilibria would lead to the different elution 
patterns for different solutes. By the use of different micellar mobile phases, the capacity factor 
of a compound on a single stationary phase would result in different values of PSM and PMW but 
identical PSW values. On the other hand, if the micellar mobile phase was constant, PMW values 
will be the same for two different stationary phases but PSW and PSM would differ (Armstrong 
and Nome, 1981; Gago et al., 1987).  
Armstrong’s partitioning model has been validated by several research groups and some 
of them have proposed variations (Foley and May, 1987; Foley, 1990; Jandera and Fischer, 
1996). Waters and co-workers (2007) have used the normalised value of the k’ to evaluate 
micelle water partition coefficients for alkyl phthalate esters. More recently, Armstrong’s 
model has been used to determine micelle-water partition coefficients (Waters et al., 2012b) as 
an alternative to the traditional octanol-water for a series of structurally and pharmacologically 
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similar pharmaceutical compounds from the class of non-steroidal anti-inflammatory drugs 
(NSAIDs). This will be discussed in detail in Chapter 4. 
1.6. Applications of MLC 
 
Micellar liquid chromatography has proved to be a versatile analytical technique with 
various applications. Since there is no need for a high purity of sample to be injected for 
analysis, direct injection of physiological fluid (for example, serum, plasma, urine) in MLC 
has made it a superior technique over other chromatographic approaches (Khaledi, 1997). This 
ensures rapid screening of samples in quick succession of time since sample preparation steps 
are far less than conventional chromatography where a high purity of sample is required. One 
such example is the direct injection of a urine sample into MLC which permits analysis of beta-
blocker drugs with a shorter run time (Martínez et al., 1999).  
MLC has been successfully applied as a separation technique for the analysis of 
pharmaceutical compounds and it has proved to be a better alternative of commonly used ion-
pair chromatography (Nishi, 1997). Hydrophilic drugs, usually unretained in RP-HPLC, are 
often retained in MLC owing to ionic interactions with the charged surfactant molecules. 
Capella-Peiró and co-workers developed a rapid screening method for analysing 
corticosteroids in various pharmaceutical formulations using direct injection in MLC (Capella-
Peiró et al., 2002). Similarly, other classes of drugs such as phenethylamines (Gil-Agustí et al., 
2000), tetracycline (Caballero et al., 2002) and tricyclic antidepressants (Ruiz-Angel et al., 
2003) have been successfully separated using MLC.  
To this end, MLC will be explored in depth as a potential alternative to the traditional 
octanol-water system for acquiring partition coefficients for compounds of pharmaceutical 
interest. In particular, the effect of the mobile phase pH and experimental temperature on the 
partitioning process will be the focus of this study as these have never been investigated prior 
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to this study. This is an important consideration for MLC as it may ultimately expand, or 
potentially limit, its potential as an alternative technique to determine partition coefficients. 
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Chapter 2: Summary of scientific literature, aim and 
objectives 
 
 
 
By far, the most common method of determining a partition coefficient is the shake 
flask method using octanol and water as partitioning media. Hydrophobic compounds can 
cause practical difficulties in measuring the octanol-water partition coefficient and may not 
truly represent the biological system because of structural differences (Seeman, 1972). 
Lipophilicity as a molecular parameter encodes both polar and hydrophobic intermolecular 
forces. However, when expressed by partition coefficients measured in the traditional octanol-
water system, lipophilicity fails to encode some important recognition forces, most notably 
ionic bonds, which are of particular importance when modeling the interaction of ionised 
compounds with membranes, therefore, un-reliable partitioning data for many solutes has been 
reported. In addition to these concerns, the traditional octanol-water partition coefficient 
determination procedure is tedious and time consuming and requires a high level of solute and 
solvent purity. Furthermore, the use of toxic organic solvent is another drawback of this 
technique (Hartmann and Schmitt, 2004; Khaledi and Breyer, 1989).   
 
The traditional view of passive transport is that hydrophilic compounds (particularly 
ions) do not permeate into and across biological membranes. However, recent experimental 
evidence invalidates this assumption and documents the distribution of ion pairs and the passive 
transport of ionic species. Indeed, it is increasingly clear that the behavior of ionisable drugs in 
the body is controlled by the interaction of both their neutral and ionised forms with biological 
membranes. The importance of partitioning of ionic and zwitterionic species in biphasic media 
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has been emphasised in connection with their pharmacokinetic and pharmacodynamic 
behaviour, and hydrophobic as well as electrostatic interactions are expected between 
biological membranes and ionised compounds (Taillardat-Bertschinger et al., 2003).  
 
The major goal for physicochemical screening is to predict human drug absorption, 
distribution, elimination, excretion and toxicity and these are all dependent on the lipophilicity.  
There is a clear necessity to replace the octanol-water partitioning process with a relatively 
more suitable process which can possibly mimic the biological partitioning process of 
pharmaceuticals and can generate more reliable data in a shorter period of time. More recently 
micellar liquid chromatography (MLC) based partition coefficients for pharmaceutical 
compounds have been reported (Waters and Kasprzyk-Hordern, 2010) as a reliable alternative 
to octanol-water. This technique utilises an aqueous mobile phase containing surfactants over 
a certain concentration where these surfactants exist in the form of aggregates known as 
micelles. Micelles partially resemble biological membranes owing to the presence of the 
hydrophilic head and a hydrophobic tail, therefore, MLC is a potential alternative to the 
traditional octanol-water system. 
 
2.1. Aims 
 
The aim of this research is to investigate and refine a simple method to acquire 
partitioning and thermodynamic data associated with the partitioning process for 
pharmaceutical compounds. Furthermore, the partitioning data acquired in this research will 
be exploited in order to evaluate its biological relevance for transdermal drug delivery systems. 
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2.2. Objectives 
 
The specific objectives to support the aims of this thesis are as follows: 
1. To develop a fast and reliable method of partition coefficient determination for 
pharmaceuticals which can mimic biological partitioning 
2. To study the influence of compounds used in this study on the size and shape of 
micelles  
3. To study the effect of pH on partition coefficient determination by micellar liquid 
chromatography 
4. To study the effect of temperature on partition coefficient determination by 
micellar liquid chromatography  
5. To compare and evaluate the partitioning data obtained as an alternative method to 
predict skin permeability  
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Chapter 3: Materials and Methods 
 
 
 
 
3.1. Chemicals 
 
Sodium dodecyl sulfate (SDS), electrophoresis grade, was purchased from Fisher 
Scientific (Loughborough, UK) with a minimum purity of 99 %. Test solutes were: 
acetylsalicylic acid 99 % (Acros Organics, Geel, Belgium), caffeine 97 % (Sigma-Aldrich, 
Dorset, UK), diphenhydramine hydrochloride 99 % (Acros Organics, Geel, Belgium), ethyl 
nicotinate 98 % (Sigma-Aldrich, Dorset, UK), ethyl paraben 98 % (Sigma-Aldrich, Dorset, 
UK), fenbufen 99 % (TCI, Oxford, UK), fenoprofen 99 % (TCI, Oxford, UK), flurbiprofen 99 
% (TCI, Oxford, UK), haloperidol 99 % (Sigma-Aldrich, Dorset, UK), hexyl nicotinate (TCI, 
Oxford, UK), ibuprofen 99 % (BASF, Cheshire, UK), indomethacin 99 % (Sigma-Aldrich, 
Dorset, UK), ketoprofen 99 % (TCI, Oxford, UK) lidocaine 98 % (Sigma-Aldrich, Dorset, 
UK), methyl nicotinate (Fluka, Dorset, UK), methyl paraben 98 % (Sigma-Aldrich, Dorset, 
UK), naproxen 99 % (Sigma-Aldrich, Dorset, UK), nicotinic acid (Sigma-Aldrich, Dorset, 
UK), paracetamol 99 % (Sigma-Aldrich, Dorset, UK), procaine hydrochloride 97 % (Sigma-
Aldrich, Dorset, UK), salicylic acid 98 % (Fisher, Loughborough, UK), thiourea 97 % (Vickers 
Lab. Ltd., Pudsey, UK) and urea 97 % (Vickers Lab. Ltd., Pudsey, UK) were used as received. 
De-ionised water was used throughout the experiments.  
The structure of chemicals along with their physicochemical properties is presented in 
Table 3.1. 
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Table 3.1: Physicochemical properties of chemicals 
Sodium Dodecyl Sulfate Structure 
Molecular weight1 288.4 g/mol 
 
Charge Anionic 
CMC 8 mM 
AN 62 
Micellar shape Spherical 
CAS no. 151-21-3 
Acetylsalicylic acid  
Molecular weight1 180.2 g/mol 
 
pKa1 3.5 
LogPOW2 1.19 
Charge Anionic 
λmax3 278 nm 
CAS no. 50-78-2 
Caffeine  
Molecular weight1 194.2 g/mol 
 
pKa1 0.52 
LogPOW2 -0.07 
Charge Neutral 
λmax3 254 nm 
CAS no. 58-08-2 
Diphenhydramine hydrochloride  
Molecular weight1 206.3 g/mol 
 
pKa1 4.41 
LogPOW2 3.6 
Charge Cationic 
λmax3 221 nm 
CAS no. 15687-27-1 
                                                          
1
 Molecular weight and pKa (dissociation constant) were generated from ACD/Labs, RSC, UK 
2
 LogPOW from literatures (Waters et al., 2012, Waters et al., 2013)  
3
 Taken from Clark’s drug analysis 
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Ethyl nicotinate Structure 
Molecular weight1 151.2 g/mol 
 
pKa1 3.3 
LogPOW2 1.3 
Charge Cationic 
λmax3 261 nm 
CAS no. 614-18-6 
Ethyl paraben  
Molecular weight1 166.2 g/mol 
 
pKa1 8.3 
LogPOW2 2.47 
Charge Anionic 
λmax3 254 nm 
CAS no. 120-47-8 
Fenbufen  
Molecular weight1 254.3 g/mol 
 
pKa1 4.55 
LogPOW2 3.2 
Charge Anionic 
λmax3 285 nm 
CAS no. 36330-85-5 
Fenoprofen  
Molecular weight1 242.3 g/mol 
 
pKa1 4.2 
LogPOW2 3.45 
Charge Anionic 
λmax3 272 nm 
CAS no. 53746-45-5 
                                                          
1
 Molecular weight and pKa (dissociation constant) were generated from ACD/Labs, RSC, UK 
2
 LogPOW from literatures (Waters et al., 2012, Waters et al., 2013) 
3
 Taken from Clark’s drug analysis 
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Flurbiprofen Structure 
Molecular weight1 244.3 g/mol 
 
pKa1 4.14 
LogPOW2 3.7 
Charge Anionic 
λmax3 247 nm 
CAS no. 5104-49-4 
Haloperidol  
Molecular weight1 357.9 g/mol 
 
pKa1 8.3 
LogPOW2 3.49 
Charge Neutral 
λmax3 245 nm 
CAS no. 52-86-8 
Hexyl nicotinate  
Molecular weight1 207.3 g/mol 
 
pKa1 3.21 
LogPOW2 3.5 
Charge Cationic 
λmax3 260 nm 
CAS no. 23597-82-2 
Ibuprofen  
Molecular weight1 206.3 g/mol 
 
pKa1 4.41 
LogPOW2 3.6 
Charge Anionic 
λmax3 221 nm 
CAS no. 15687-27-1 
                                                          
1
 Molecular weight and pKa (dissociation constant) were generated from ACD/Labs, RSC, UK 
2
 LogPOW from literatures (Waters et al., 2012, Waters et al., 2013) 
3
 Taken from Clark’s drug analysis 
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Indomethacin Structure 
Molecular weight1 357.8 g/mol 
 
pKa1 4.18 
LogPOW2 3.51 
Charge Anionic 
λmax3 230 nm 
CAS no. 53-86-1 
Ketoprofen  
Molecular weight1 254.3 g/mol 
 
pKa1 4.23 
LogPOW2 2.7 
Charge Anionic 
λmax3 262 nm 
CAS no. 22071-15-4 
Lidocaine  
Molecular weight1 234.3 g/mol 
 
pKa1 7.9 
LogPOW2 2.3 
Charge Cationic 
λmax3 220 nm 
CAS no. 137-58-6 
Methyl nicotinate  
Molecular weight1 137.1 g/mol 
 
pKa1 3.19 
LogPOW2 0.8 
Charge Cationic  
λmax3 264 nm 
CAS no. 93-60-7 
                                                          
1
 Molecular weight and pKa (dissociation constant) were generated from ACD/Labs, RSC, UK 
2
 LogPOW from literatures (Waters et al., 2012, Waters et al., 2013) 
3
 Taken from Clark’s drug analysis 
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Methyl paraben Structure 
Molecular weight1 152.1 g/mol 
 
pKa1 8.4 
LogPOW2 1.96 
Charge Anionic 
λmax3 257 nm 
CAS no. 99-76-3 
Naproxen  
Molecular weight1 230.3 g/mol 
 
pKa1 4.8 
LogPOW2 3.2 
Charge Anionic 
λmax3 262 nm 
CAS no. 22204-53-1 
Nicotinic acid  
Molecular weight1 123.1 g/mol 
 
pKa1 4.8 
LogPOW2 0.4 
Charge Anionic 
λmax3 263 nm 
CAS no. 59-67-6 
Paracetamol  
Molecular weight1 151.2 g/mol 
 
pKa1 9.8 
LogPOW2 0.5 
Charge Neutral 
λmax3 243 nm 
CAS no. 103-90-2 
                                                          
1
 Molecular weight and pKa (dissociation constant) were generated from ACD/Labs, RSC, UK 
2
 LogPOW from literatures (Waters et al., 2012, Waters et al., 2013) 
3
 Taken from Clark’s drug analysis 
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Procaine hydrochloride Structure 
Molecular weight1 236.3 g/mol 
 
pKa1 9.0 
LogPOW2 2.2 
Charge Cationic 
λmax3 294 nm 
CAS no. 51-05-8 
Salicylic acid  
Molecular weight1 138.1 g/mol 
 
pKa1 13.06 
LogPOW2 2.26 
Charge Anionic 
λmax3 236/298 nm 
CAS no. 69-72-7 
Thiourea  
Molecular weight1 76.1 g/mol 
 
pKa1 13.0 
LogPOW2 -0.95 
Charge Neutral 
λmax3 238 nm 
CAS no. 62-56-6 
Urea  
Molecular weight1 60.1 g/mol 
 
pKa1 14.3 
LogPOW2 -2.11 
Charge Neutral 
λmax3 280 nm 
CAS no. 57-13-6 
                                                          
1
 Molecular weight and pKa (dissociation constant) were generated from ACD/Labs, RSC, UK 
2
 LogPOW from literatures (Waters et al., 2012, Waters et al., 2013) 
3
 Taken from Clark’s drug analysis 
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3.2. Instrumentation 
 
The HPLC system comprised of a Severn Analytical solvent delivery system 
(SA6410B). A Rheodyne injector with 20 µL loop volume was attached for sample injection. 
Separation of solutes was performed using a reverse phase cyanopropyl bonded stationary 
phase column (spherisorb 5 µL, 15 cm × 4.6 mm i.d). The temperature of the column was 
maintained using a Jones Chromatography column heater and chiller (Model 7950). A UV 
detector (Waters UV/Vis, 2487) was attached with the HPLC system for the detection of 
eluents.  
3.3. Mobile phase 
 
The mobile phase was prepared by dissolving an accurately weighed amount of SDS in 
de-ionised water over a concentration range of 0.01 – 0.03 M. The mobile phase was sonicated 
to ensure removal of air bubbles prior to the start of experiments. Mobile phase was freshly 
prepared on a daily basis and the pH of the mobile phase was measured with a pre-calibrated 
pH meter (Jenway 3305, UK). 
3.4. Measurement of dead time (to) 
 
An important point in MLC is the determination of dead time (to), which is the time 
taken by the solvent front to reach the detector. In literature, various procedures have been 
documented that describe the measurement of dead time including injection of water (Pramauro 
et al., 1988), salt solutions such as NaNO3 (Borgerding et al., 1989), sodium or potassium 
iodide (Pramauro and Pelizzetti, 1983), or organic solvents such as methanol or acetonitrile 
(Khaledi et al., 1987; Khaledi, 1988). The criteria described in the literature to locate the dead 
time uses the position of the maximum or minimum perturbation in the chromatogram, i.e. the 
time from the injection to the appearance of the first deviation in the base line. The use of small 
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compounds like sodium or potassium iodide is based on the assumption that they will not 
interact with the stationary phase and their appearance at the detector reflects the dead time. 
However, these methods remain questionable for assessing the real dead times, although the 
measured times were proven suitable for this purpose (Torres-Lapasió et al., 1996). 
In this work, dead time was measured by either injecting water or acetonitrile (20 µL) 
through the column and the time to the first major deviation recorded as exemplified in Figure 
3.1. This procedure was repeated for all surfactant concentrations (0.01 – 0.03 M) with at least 
ten replicates to get a reliable value for dead time. The average to value was 50 seconds which 
was used in all experiments for the determination of capacity factor k’ using Equation 3. 
It should be noted that a new UV detector was installed on the HPLC system during this 
study which resulted in an alteration in the length of the HPLC tubes. Therefore, it was 
necessary to determine the dead time value for that system. The resultant dead time was 
recorded to be 20 seconds which was used for the calculation of capacity factors.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1: Dead time of the column at 0.03 M surfactant concentration 
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3.5. Small angle X-ray scattering (SAXS) measurements 
 
Micelle-water partition coefficients measured through MLC depend on the geometry of 
micelles, therefore, it was necessary to investigate the effect of added drug on the size of 
micelles in the studied range of surfactant concentration. 
Two-dimensional small-angle X-ray scattering (2D-SAXS) patterns were measured 
using a Nanostar camera (Bruker). This apparatus was fitted with an air-cooled microbeam X-
ray generator, operated at 50 kV and 600 µA, producing Cu Kα radiation (wavelength, λX = 
0.15418 nm). The scattered light was collected using a Vantec 2000 detector, which resolved 
the intensity patterns into 2048  2048 pixels. A lead beamstop was suspended in front of the 
detector, to block the direct (i.e. unscattered) light. The sample-to-detector distance was 
0.678 m, as determined by calibration against a silver behenate reference, corresponding to a 
range of the scattering angle (2θ) of roughly 0 to 5°.   
Samples consisting of 0.05 M sodium dodecyl sulfate (SDS) in water were held in 
quartz capillaries (ca. 1.5 mm internal diameter). This was compared with samples containing 
0.2 mM ibuprofen (anionic), paracetamol (neutral) and lidocaine (cationic). The maximum 
working concentration of SDS in MLC was 0.03 M which did not give any significant 
scattering using Nanostar, therefore, for the proof of concept a concentration of 0.05 M was 
selected. Measurements were performed at an ambient temperature (ca. 25 °C inside the sample 
chamber). To prevent leakage, the sample chamber was maintained at atmospheric pressure, 
with mylar windows to separate it from the rest of the optical path, which was held under 
vacuum. Acquisition times of 12 hours were used and samples were measured in duplicate, to 
further improve the signal-to-noise ratio. 
‘Background’ scattering due to the sample capillaries, air in the sample chamber, the 
X-ray windows and any other elements of the apparatus was determined using a blank solution 
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consisting of 0.005 M SDS solution (i.e. below the critical micelle concentration). The resulting 
intensity patterns were subtracted from the SAXS data, after suitable scaling, to allow for 
sample absorbance. 
Since the scattering patterns were circularly symmetrical, the intensity maps were 
resolved into radial plots of intensity against scattering angle, by performing azimuthal 
integrations, using the SAXS for Windows software provided. The resulting intensity curves 
were plotted against the modulus of the scattering vector, which is defined as: 
 sin4Xq 
                                                                      
                       (3.1) 
where q is the scattering vector, λ is the radiation wavelength and θ is the scattering angle. 
The micelle structures were analysed by fitting an appropriate model to the scattering 
data for each SDS concentration, using the ‘Solver’ tool in Excel (Microsoft). It was assumed 
that the electron densities in the micelle core (assumed to be pure hydrocarbon) and the 
continuous liquid medium (assumed to be pure water) remained constant, while the average 
size of the micelle, the thickness and composition of its surface layer, the thickness of a further 
bound layer and an overall intensity factor were allowed to change, in order to fit the model to 
the data. 
3.6. Chromatographic procedure  
 
Mobile phase was pumped through the chromatographic system using the solvent 
delivery system (SA 6410B) with a flow rate of 1.35 mL per minute. Each 0.2 mM drug sample 
was prepared in an aqueous solution of SDS equivalent to the mobile phase concentration. The 
concentration of drug in each sample was kept to a minimum to avoid saturation of the column 
with the drug and to refute the chances of any change in the micelle size and geometry. Each 
 
62 
20 µL sample was injected via the Rheodyne injector into the system. UV detection was set at 
a specified wavelength (λmax) for each drug as given in Table 3.1.  
Each run was repeated six times to achieve statistically significant retention time (tr) 
data. After every sixth run, the mobile phase was diluted to the next specified concentration 
using de-ionised water. The system was left for 25-30 minutes for equilibrium to be attained 
and repeated for all specified mobile phase concentrations. From the data obtained, capacity 
factors were calculated using Eq. (1.2). The partition coefficient was measured by plotting the 
inverse of the capacity factor (1/k’) against the micelle concentration (CM) where CM is the 
micelle concentration obtained by subtracting the CMC from the total surfactant concentration. 
3.6.1. pH controlled experiments 
 
Experiments were conducted at a controlled pH of the mobile phase over a range from 
3.0 to 7.0 (i.e. the operational pH range for cyanopropyl column) values. The pH of the mobile 
phase was adjusted using a 0.1 M phosphate buffer system. All the samples were prepared in 
the mobile phase of respective pH. When necessary, an acidic pH was achieved by adding 10 
% H3PO4. 
For skin permeability predictions (Chapter 7), chromatographic data was collected at a 
mobile phase pH of 5.5 at 35 ± 1ºC in order to mimic the skin pH conditions.  
3.6.2. Temperature controlled experiments 
 
Temperature of the mobile phase and sample was controlled by immersion in a 
thermostatic water bath maintained at the same temperature as that of the stationary phase. A 
Jones column heater was used to systematically maintain the column temperature. Retention 
data was obtained over a range of temperatures (295 K – 317 K) to allow determination of the 
thermodynamics of the partitioning process. The experimental PMW was used to calculate the 
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change in the Gibb’s free energy (ΔG) as described by Eq. (1.18). Thermodynamic data was 
obtained by applying the van’t Hoff isochore which may permit the calculation of a change in 
enthalpy (ΔH) and entropy (ΔS) of the partitioning process from the slopes and intercepts of 
the plots.  
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Chapter 4: Determination of chromatographic based 
partition coefficients for pharmaceutical compounds 
 
This chapter highlights the measurement of partition coefficients and the mechanisms behind 
the retention of compounds in micellar liquid chromatography (MLC). The impact of 
physicochemical properties of the compounds on their retention on the stationary phase and 
interaction with the micelles will be explored in depth. Micelle-water partition coefficients will 
be determined using Armstrong’s partitioning model and values will be compared with those 
from literature based on other techniques. 
 
4.1. Introduction 
 
This research uses MLC to determine micelle-water partition coefficients for 
compounds of pharmaceutical interest as an alternative to traditional methods. The unique 
selectivity of such systems is a result of the micellar core, which offers a hydrophobic site of 
interaction for non-polar drugs in an aqueous phase. This ‘protection’ is based on the 
association of the solute with the micelle through a combination of factors including 
adsorption, electrostatic, and steric interactions (Armstrong and Nome, 1981; Berthod et al., 
1986a). Micelles in aqueous solutions offer various microenvironments: the hydrophobic core, 
the head group region in contact with water and an aqueous region outside the micelle, thus, 
closely mimicking biomembranes (Ingram et al., 2013). This creates a unique situation in 
which solutes can occupy various locations inside the micelle or on the surface of micelle and 
face various polarities in the given micellar mobile phase (Khaledi and Breyer, 1989). 
Therefore, retention behaviour in micellar liquid chromatography is dissimilar to that with 
more conventional hydro-organic mobile phases, such as those currently used in the 
pharmaceutical industry. 
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 Utilisation of micelles in MLC for partition coefficient determination has recently been 
considered as a superior and potential alternative technique to those used for determining 
traditional octanol-water partition coefficients (Waters and Kasprzyk-Hordern, 2010; Waters 
et al., 2007). MLC accounts for three types of partition coefficients, as described in Chapter 
One, which makes MLC a technique that has the ability to quickly, precisely and unequivocally 
evaluate the partition coefficients of solutes between micelle and water (PMW) for a chosen 
surfactant system. 
Most of the previous reports for determining solutes in MLC make use of a micellar mobile 
phase containing an organic modifier, usually a short chain alcohol, to improve the 
chromatographic efficiency (García-Alvarez-Coque et al., 1997). However, the presence of an 
organic modifier in the micellar mobile phase may alter the CMC, AN and polarity of the 
aqueous phase which results in an additional interaction with the solute. This study has 
involved the development of a method that does not require an organic modifier, thus 
overcoming this issue.  
It is widely accepted that surfactant adsorption onto porous silica based columns 
drastically affects the chromatographic retention, owing to the surface properties of the 
stationary phase. The decreasing order of surfactant adsorption on various stationary phases of 
different polarities as reported by Berthod and co-workers (1986a; 1986b) is octadecyl (C18), 
octyl (C8), methyl (C1), cyanopropyl (CN) and bare silica. Thus, the more hydrophobic the 
stationary phase, the more surfactant will be adsorbed, i.e. adsorption of surfactants on CN 
based columns is lower than C8 and C18 columns. Therefore, it is possible to state that the 
distribution of solute between the aqueous phase and micelles (PMW) would largely represent 
the partitioning behaviour of solutes if a CN based column is used. Additionally, the nature of 
interactions that are established between solutes, surfactant-modified stationary phases and 
micelles also influences the partitioning behaviour. On the basis of these interactions, solutes 
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either bind to the micelle (binding solutes), do not bind to the micelle (non-bonding) or are 
repelled by the micelle (anti-binding) (Armstrong and Stine, 1983).  
It should be noted that there are certain assumptions applied to the Armstrong model that 
describe the retention of the solutes in MLC (Ruiz-Ángel et al., 2009): 
1- The aggregation number and geometry of micelles is not altered with increasing 
concentration of surfactants.  
2- The CMC is not altered with the addition of small amounts of solutes in the 
chromatographic system 
3- Binding of surfactant to the stationary phase reaches saturation level at, or before, the 
CMC of the surfactant is reached. 
4- The stoichiometry of the solute-micelle complex is 1:1. 
In this set of experiments, a CN based reverse phase column was employed in an attempt 
to take advantage of a reduced interaction between the stationary phase and the twelve carbon 
containing surfactant, namely SDS for the determination of partition coefficients of selected 
compounds.  
4.2. Results and discussion 
 
4.2.1. Small angle X-ray scattering (SAXS) measurements 
 
Small-angle X-ray scattering is a powerful tool for determining the structure of 
colloidal particles, macromolecules and macroions in solution. Particularly in the case of 
micelles, this method can in principal measure parameters such as the micelle geometry (size 
and shape) and extent of water penetration. Geometry of micelle, especially those formed from 
surfactant monomers, depends upon various factors including added drug molecules or salt to 
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the surfactant solution. In this study, the effect of added drug (cationic, neutral and anionic) on 
the size of micelles was studied using SAXS.  
SAXS patterns for 0.05 M SDS solutions with and without drugs are presented in Figure 
4.1. All the SAXS patterns shown a peak at about q = 1.7 nm-1, characteristic of the intra-
micellar form factor (Itri and Amaral, 1993). The presence of a second inner peak around q= 
0.4 nm-1 is a ﬁngerprint of an interference function due to the interaction between charged 
micelles (Itri and Amaral, 1993). However, there was no difference observed in these peaks in 
the presence of drugs (Figure 4.1), confirming a stable geometry of the micelle with the 
addition of anionic, neutral and cationic drugs. Since the scattering patterns were circularly 
symmetrical (not shown here), the shape of the micelles was deemed spherical at the studied 
surfactant concentration range with and without the addition of drugs. 
 
 
Figure 4.1: Plots of intensity vs. modulus of the scattering vector, 0.05 M SDS solutions 
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4.2.2. Micelle-water partition coefficients 
 
Micelle-water partition coefficients were determined for seven drugs using SDS and 
MLC. An accurate determination of PMW requires a precise modelling of retention times 
especially when the efficiencies achieved are rather low. The retention model in MLC relates 
a solutes capacity factor with the mobile phase composition, thus avoiding the dependency of 
the model on the flow rate of mobile phase. However, the capacity factor is prone to errors if 
the dead time is unreliable. Torres-Lapasió and co-workers (Torres-Lapasió et al., 1996) have 
described the influence of dead time on the prediction of capacity factors for five different 
compounds. According to their findings, the end results were severely affected by the value 
taken for the dead time and indicated large errors in the determination of physicochemical 
properties, for instance the association constants between micelles and the solutes.  Therefore, 
a precise dead time measurement was necessary before proceeding with the MLC based 
partition coefficients measurement. The mean value for the dead time at all surfactant 
concentrations was 50 seconds or 20 seconds as explained earlier (see section 3.4).  
To cover a broad range of solutes, anionic drugs (ibuprofen and ketoprofen), cationic 
drugs (diphenhydramine, lidocaine and procaine) and neutral drugs (paracetamol and caffeine) 
were chosen for an evaluation of MLC to determine partition coefficients. The chromatograms 
of the seven drugs considered in this study (at various surfactant concentrations) are presented 
in Figures 4.2 – 4.8.  
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Figure 4.2: Chromatograms of ibuprofen at room temperature obtained using MLC 
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Figure 4.3: Chromatograms of ketoprofen at room temperature obtained using MLC 
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Figure 4.4: Chromatograms of caffeine at room temperature obtained using MLC 
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Figure 4.5: Chromatograms of paracetamol at room temperature obtained using MLC 
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Figure 4.6: Chromatograms of diphenhydramine at room temperature obtained using MLC 
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Figure 4.7: Chromatograms of lidocaine at room temperature obtained using MLC 
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Figure 4.8: Chromatograms of procaine at room temperature obtained using MLC 
 
It should be noted that the pH of the mobile phase, consisting of the highest (0.03 M) 
and the lowest (0.012 M) SDS concentration, was recorded before injecting samples into the 
MLC system in order to probe the state of the drugs within the column which could foresee the 
possible interactions between solutes, stationary phase and the micelles. The pH of the mobile 
phase was consistently in the range of 5.6 – 6.2 which suggests all the solutes were in their 
ionised form. The retention behaviour depends on how a drug interacts with the surfactant 
modified stationary phase and the micelle. Obviously, the charge on the ionised species will be 
the most important factor in describing these interactions. Drugs with both positive and 
negative charges, i.e. relatively neutral drugs overall, would have non-polar, dipole-dipole 
and/or proton donor-accepter interactions. The charged species of the drugs will interact 
electrostatically with the ionic surfactant, i.e. anionic drugs are expected to be repelled by the 
net negative charge on the head groups of the micelles, while cationic drugs will have an 
attraction for the negatively charged SDS micelles. Depending on the degree of ionisation, this 
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will result in an ‘apparent’ rather than ‘absolute’ value for the PMW. Ionised drugs will have an 
increased aqueous solubility, compared with un-ionised, and therefore the ‘apparent’ PMW will 
appear lower in value than an absolute value (Waters and Kasprzyk-Hordern, 2010).  
Capacity factors (k’) were calculated from the retention times of solutes at five 
surfactant concentrations, collected at an ambient temperature (295 K), with the relevant 
chromatographic data for the seven drugs presented in Tables 4.1 – 4.7.  
 
Table 4.1: A summary of chromatographic data for ibuprofen 
SDS conc. (M) Mean retention time (tr) in seconds k’ 1/k’ CM  (M) 
0.030 66.2 0.33 3.05 0.022 
0.025 64.3 0.29 3.44 0.017 
0.020 63.3 0.27 3.69 0.012 
0.016 61.8 0.24 4.15 0.008 
0.012 60.8 0.22 4.53 0.004 
 
 
 
 
Table 4.2: A summary of chromatographic data for ketoprofen 
SDS conc. (M) Mean retention time (tr) in 
seconds k’ 1/k’ CM  (M) 
0.030 59.0 0.29 3.43 0.022 
0.025 64.0 0.40 2.49 0.017 
0.020 67.0 0.47 2.14 0.012 
0.016 69.0 0.51 1.96 0.008 
0.012 72.0 0.58 1.73 0.004 
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Table 4.3: A summary of chromatographic data of caffeine 
SDS conc. (M) Mean retention time (tr) in 
seconds k’ 1/k’ CM  (M) 
0.030 100.0 1.00 1.00 0.022 
0.025 101.0 1.02 0.98 0.017 
0.020 103.0 1.06 0.94 0.012 
0.016 106.0 1.12 0.89 0.008 
0.012 111.0 1.22 0.82 0.004 
 
 
Table 4.4: A summary of chromatographic data of paracetamol 
SDS conc. (M) Mean retention time (tr) in 
seconds k’ 1/k’ CM  (M) 
0.030 82.5 0.66 1.52 0.022 
0.025 84.0 0.69 1.45 0.017 
0.020 85.5 0.72 1.39 0.012 
0.016 87.0 0.75 1.33 0.008 
0.012 88.0 0.77 1.30 0.004 
 
 
Table 4.5: A summary of chromatographic data of diphenhydramine 
SDS conc. (M) Mean retention time (tr) in 
seconds k’ 1/k’ CM  (M) 
0.030 41.0 1.02 0.98 0.022 
0.025 45.0 1.21 0.82 0.017 
0.020 45.8 1.25 0.80 0.012 
0.016 47.0 1.31 0.76 0.008 
0.012 51.0 1.51 0.66 0.004 
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Table 4.6: A summary of chromatographic data of lidocaine 
SDS conc. (M) Mean retention time (tr) in 
seconds k’ 1/k’ CM  (M) 
0.030 84.8 0.70 1.42 0.022 
0.025 93.3 0.87 1.15 0.017 
0.020 109 1.19 0.84 0.012 
0.016 141 1.83 0.55 0.008 
0.012 191.2 2.84 0.35 0.004 
 
 
Table 4.7: A summary of chromatographic data of procaine 
SDS conc. (M) Mean retention time (tr) in 
seconds k’ 1/k’ CM  (M) 
0.030 65 0.44 2.27 0.022 
0.025 77 0.54 1.85 0.017 
0.020 92 0.78 1.28 0.012 
0.016 102 1.04 0.96 0.008 
0.012 136 1.60 0.63 0.004 
 
 
Once the relevant chromatographic data was obtained, the inverse of the capacity 
factors (1/k’) were plotted against the concentration of micelles (CM) in the mobile phase. This 
firstly requires subtraction of the CMC of SDS from the total amount of surfactant used. The 
CMC of SDS considered in this study was 0.008 M (Waters et al., 2007). As a result, linear 
plots were obtained with an appreciable linearity (R2 ranged from 0.919 - 0.997) as shown in 
Figures 4.9 – 4.15. 
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Figure 4.9: Plot of 1/k’ of ibuprofen as a function of CM in an un-buffered SDS mobile phase 
at room temperature 
 
 
 
 
Figure 4.10: Plot of 1/k’ of ketoprofen as a function of CM in an un-buffered SDS mobile 
phase at room temperature 
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Figure 4.11: Plot of 1/k’ of caffeine as a function of CM in an un-buffered SDS mobile phase 
at room temperature 
 
 
 
 
Figure 4.12: Plot of 1/k’ of paracetamol as a function of CM in an un-buffered SDS mobile 
phase at room temperature 
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Figure 4.13: Plot of 1/k’ of diphenhydramine as a function of CM in an un-buffered SDS 
mobile phase at room temperature 
 
 
 
 
Figure 4.14: Plot of 1/k’ of lidocaine as a function of CM in an un-buffered SDS mobile 
phase at room temperature 
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Figure 4.15: Plot of 1/k’ of procaine as a function of CM in an un-buffered SDS mobile phase 
at room temperature 
 
The micelle-water partition coefficient (PMW) was determined from the ratio of the slope 
and the intercept obtained from the relationship of the inverse of the capacity factors (1/k’) and 
the concentration of micelles (CM), as described by Armstrong and Nome (1981) and 
Arunyanart and Cline Love (1985). The experimental PMW values obtained from MLC and their 
logarithmic form (logPMW) for seven model drugs are listed in Table 4.8 along with the 
literature octanol-water partition coefficient (logPOW) values. 
Table 4.8: MLC based partition coefficients for seven compounds  
Compound PMW LogPMW LogPOW LogD* at mobile phase pH 
A
n
io
ni
c Ibuprofen 16.83 ± 0.34 1.23 ± 0.01 3.6  
(Waters et al., 2012) 
1.9 
Ketoprofen 60.93 ± 4.25 1.78 ± 0.04 2.7 
 (Waters et al., 2012) 
1.1 
N
eu
tr
a
l Caffeine 12.94 ± 1.05 1.12 ± 0.04 
-0.07  
(Waters et al., 2012) 
-0.6 
Paracetamol 10.29 ± 0.40 1.01 ± 0.02 
0.5  
(Machatha and 
Yalkowsky, 2005) 
0.5 
y = 93.231x + 0.2239
R² = 0.996
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C
a
tio
n
ic
 
Diphenhydramine 25.69 ± 0.17 1.41 ± 0.00 3.3  
(Liu et al., 2003) 
0.4 
Lidocaine 1297.14 ± 13.74 3.11 ± 0.45 2.4  
(Thomas et al., 2007) 
0.4 
Procaine 416.25 ± 9.34 2.62 ± 0.33 2.1  
(Waters et al., 2012) 
-0.6 
(Results are presented as mean ± SD; n = 5); *Calculated from ACD software (ACD/Labs, RSC, 
UK). 
 
In MLC, it is expected that an increase in the concentration of surfactant in the mobile 
phase results in a decreased retention of solutes. However, this is not true if the interaction 
between solute and micelle is weak or the solute is electrostatically repelled (Ruiz-Ángel et al., 
2009). It has been previously reported that only completely nonpolar solutes can reside in the 
micellar core (Attwood and Florence, 1983). Although most hydrophobic compounds are 
predominantly non-polar and only a small fraction of the molecule contains polar groups, the 
latter would affect the location of the solute in the micelle. 
Ibuprofen and ketoprofen are weakly acidic drugs having pKa’s of 4.41 (Waters et al., 
2012) and 4.23 (Waters et al., 2012), respectively. It has been previously reported that the 
experimental octanol-water partition coefficient of ibuprofen and ketoprofen are 3.5 and 2.67 
at 298 K, respectively (Waters et al., 2012). At the mobile phase pH, carboxylic groups on both 
drugs are fully exposed to the aqueous environment of the mobile phase which brings a net 
negative charge on the ionisable group, thus, making these drugs anionic. In the case of 
ibuprofen, the retention was increased with increasing surfactant concentration (Figure 4.9) 
which depicts an anti-binding of ibuprofen with anionic surfactant. The electrostatic force of 
repulsion repelled the drug molecule from the micelle thus forcing it to be retained on the 
stationary phase through hydrophobic interactions. Since cyano (CN) based columns tend to 
adsorb less surfactant, it is expected that these stationary phases offer hydrophobic interactions 
with solutes in the presence of surfactants and anti-binding phenomena can be observed. On 
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the contrary, conventional C8 and C18 columns tend to adsorb larger amounts of surfactant, 
therefore, anti-binding phenomena are hardly observed in those stationary phases (Ruiz-Ángel 
et al., 2009).  
The experimental logPMW for ibuprofen was found to be 1.23 ± 0.01 which suggests it 
preferred the aqueous phase slightly more than expected. This means the ionised form of 
ibuprofen has been electrostatically repelled from entering the hydrophobic micellar core. 
Further to this argument, the decrease in retention at lower surfactant concentration may be 
attributed to overcoming the electrostatic repulsion between negatively charged micelles and 
ibuprofen as less micelles are present in the mobile phase. Therefore, the presence of more 
ibuprofen molecules than SDS micelles, saturates the available micelles, thus, elution of 
ibuprofen was closer to the column’s dead time because of the low adsorption of micelles onto 
the surfactant saturated stationary phase. 
Ketoprofen is a slightly less hydrophobic drug than ibuprofen (logPOW = 2.7) (Waters 
et al., 2012), and has shown an increased retention with a decrease in surfactant concentration 
(Figure 4.10). Although, ketoprofen is ionised at the mobile phase pH, it appears to favour the 
hydrophobic micellar core more than expected. This could be a result of the polarity of 
ketoprofen which is less than ibuprofen. Ketoprofen is structurally more apolar than ibuprofen, 
therefore, a higher logPMW (1.78 ± 0.04) value was achieved. Water tends to expel apolar 
solutes which counter-balance the electrostatic repulsion between the negatively charged 
ketoprofen and SDS micelle, therefore, there is more chance of ketoprofen residing inside the 
hydrophobic core of the micelle. The resultant increase in retention time is a result of the direct 
transfer of solute from micelle to the stationary phase where it is adsorbed slightly longer than 
expected owing to the hydrophobic interactions. 
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Micelle-water partition coefficients for cationic drugs, namely diphenhydramine, 
lidocaine and procaine were also determined to compare with the partitioning of anionic drugs. 
It was expected that cationic drugs would bind to the micelles through electrostatic interactions 
and have more chance of residing in the micellar core as a result of hydrophobic interactions. 
The octanol – water partition coefficients for diphenhydramine, lidocaine and procaine are 3.3, 
2.4 and 2.1, respectively (Waters et al., 2013; Liu et al., 2003). The dissociation constants (pKa) 
for diphenhydramine, lidocaine and procaine are 8.9, 7.9 and 9.0 respectively (Waters et al., 
2013; Liu et al., 2003). It should be noted that all three cationic drugs are in their ionised form 
at the mobile phase pH, therefore, binding to the micelle would be significant for these drugs. 
On closely analysing the retention behaviour of these drugs (Figures 4.6 – 4.8), all three drugs 
have strong binding to the micelle and the retention time increased as the concentration of 
surfactant decreased in the mobile phase. Although significant peak tailing was observed at 
lower surfactant concentrations (as a result of the basicity of these compounds), this was not 
an issue in the calculation of micelle – water partition coefficients. 
The experimental logPMW values for diphenhydramine, lidocaine and procaine were 
found to be 1.41 ± 0.00, 3.11 ± 0.45 and 2.62 ± 0.33, respectively as shown in Table 4.8. These 
compounds are in their ionised form, therefore, logPMW values reported here correspond to 
their ‘apparent’ partition coefficients. The logPMW for diphenhydramine was the lowest among 
the three studied cationic drugs suggesting its preference for the aqueous phase despite its high 
logPOW (3.14) (Liu et al., 2003). This result is further supported by the logD value of 0.4 at the 
mobile phase pH which clearly shows its increased preference for the aqueous phase. More 
interestingly, diphenhydramine was not retained on the CN column for longer times at various 
surfactant concentrations (Figure 4.6), which might be attributed to the self-micellisation of 
this drug. Diphenhydramine has colloidal properties and an amphiphilic structure. It has been 
reported that light-scattering measurements on these compounds have clearly produced plots 
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with distinct inflection points identical to the CMC inflection points for conventional surfactant 
molecules (Attwood and Florence, 1983). This may have affected the results obtained. 
Lidocaine and procaine, which both belong to the same class of local anaesthetics, have 
shown a strong association with the micelle which is evident from the logPMW values of both 
compounds. Since both compounds are in their ionised form, it is expected that a strong 
electrostatic attraction would exist between each cationic drug and the negatively charged 
surfactant head group. Furthermore, it would seem that the drug is distributed in the micellar 
core as well as on the surface of the micelle which is evident from the higher logPMW values. 
At lower surfactant concentrations, the number of available micelles is significantly reduced 
and saturation of micelles would occur. This results in a relatively high amount of free drug 
available to interact with the stationary phase, thus, extending the retention times (Figures 4.7 
and 4.8).  
LogD values of 0.4 and -0.6 for lidocaine and procaine, respectively, at the pH of the 
mobile phase suggest that these drugs should prefer the aqueous phase in their ionised form. 
Conversely, this was not true in the presence of the micellar mobile phase and both drugs have 
shown a high preference for the micelles as a result of hydrophobic and electrostatic 
interactions. Although, logPMW and logPOW are relatively similar for lidocaine and procaine in 
this study, it can still be said MLC provides a better mimic of biological partitioning since it 
encodes electrostatic, as well as hydrophobic, interactions.  
Two neutral drugs (compounds that acquire both negative and positive charges on 
ionisation) were used to compare chromatographic data with the anionic and cationic drugs. 
This was achieved by determining MLC based partition coefficients for two model drugs, 
namely caffeine and paracetamol. Caffeine is a freely water soluble drug with a logPOW value 
of -0.07 (Waters and Kasprzyk-Hordern, 2010), while paracetamol is a slightly hydrophobic 
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drug with a logPOW value of 0.5 (Machatha and Yalkowsky, 2005). The retention of caffeine 
and paracetamol increased with decreasing concentration of surfactant in the mobile phase 
(Figures 4.11 and 4.12). This represents a normal binding phenomenon in MLC which shows 
a preference by the compounds for the micelles. The experimental logPMW values were found 
to be 1.12 ± 0.04 and 1.01 ± 0.02 for caffeine and paracetamol, respectively, which is higher 
than the traditionally determined logPOW values. This increase in partition coefficient value was 
attributed to the preference of caffeine and paracetamol to either reside in the hydrophobic core 
of the micelle or stay at the surface (palisade layer) of the micelle. On closely analysing the 
retention behaviour of these two drugs, the retention time for caffeine was from 100 to 111 
seconds and that for paracetamol was 82 to 88 seconds at all surfactants concentrations (Table 
4.3 and 4.4). Although, the retention time was higher than that for most of the anionic and 
cationic drugs, there was no significant difference in the retention times between the highest 
(0.03 M) and lowest (0.012 M) surfactant concentrations. Therefore, it is possible to 
hypothesise that both of these drugs were mainly located at the surface (or palisade region) of 
the micelle, i.e. some part of the drug molecule would be facing the aqueous phase resulting in 
the retention of drug through interactions with the stationary phase.  
In short, the ionisable drugs studied have demonstrated a superior micelle-water 
partitioning process, compared with the traditional octanol-water system which considers only 
the un-ionised form of drugs, and therefore fails to describe partitioning of ionised compounds 
such as those considered in this study.  
 
4.3. Conclusion 
 
MLC based partition coefficients for anionic, neutral and cationic drugs were evaluated. 
Owing to the structural resemblance of micelles to biomembranes, MLC is a potential 
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alternative to the traditional octanol-water system for the accurate measurement of partition 
coefficients. Data acquisition is quick and the results are reproducible. Drugs with various 
polarities have shown a broad range of lipophilicity in terms of logPMW values. In all cases, 
partitioning of drugs solely into the micellar core was not the only factor, in fact, interaction of 
charged and neutral species with the surface of the micelle was an important factor in 
explaining partition coefficients determined through MLC. 
However, drugs usually have ionisable groups, which may interact differently with the 
micelle and the stationary phase, therefore, systematic control of ionisation through controlling 
the pH of the mobile phase would be extremely beneficial.  
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Chapter 5: Influence of mobile phase pH on 
partitioning  
 
 
1This chapter highlights pH effects on the measurement of partition coefficients using micellar 
liquid chromatography (MLC). The impact of ionisation of the compounds on their retention 
on the stationary phase and interaction with micelles will be explored in depth. From this, 
correlations will be developed with pH, ionisation and computational logD values. 
 
5.1. Introduction 
 
Retention behaviour of acidic solutes is greatly influenced by the pH of the mobile phase 
in conventional reverse phase HPLC. Small changes in pH can significantly alter 
chromatographic retention, particularly when it is close to the dissociation constant (pKa) of 
the solute (Palmisano et al., 1989; Haginaka et al., 1989; Love and Fett, 1991). However, 
literature reporting pH effects on micellar chromatographic retention of compounds is scarce, 
especially with reference to the cyano-bonded stationary phase. Most reports suggest that the 
mobile phase pH has a fundamental impact on the gradient of the inverse of capacity factor 
with micelle concentration (Arunyanart and Cline Love, 1985; Rodgers and Khaledi, 1994). 
This is because retention of organic solutes on alkyl-bonded stationary phases showing acid-
base behaviour is highly dependent on the pH of the mobile phase (García-Alvarez-Coque et 
al., 1997). Retention of the acidic and basic species of an organic solute will differ in the 
micellar pseudophase as a consequence of shifts in the dissociation constant in the micellar 
mobile phase. Previous reports also suggest that the retention of acidic and basic species 
                                                          
1
 Sections of this chapter have been published, see Appendix A 
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follows sigmoidal behaviour at varying pH values (Arunyanart and Cline Love, 1985; Rodgers 
and Khaledi, 1994; García-Alvarez-Coque et al., 1997). 
As discussed in Chapter 4, cyanopropyl (CN) columns interact in a different way with 
ionic surfactants compared with conventional alkyl-bonded columns. Firstly, adsorption of 
ionic surfactants is minimal on the neutral stationary phase. Secondly, the surfactant 
hydrophobic tail is oriented towards the mobile phase, thus offering hydrophobic interactions 
(Ruiz-Ángel et al., 2009), therefore, cyano-bonded stationary phases generally have the 
capability to retain various ionic species.  
In this chapter, micelle – water partition coefficient values were determined over a range 
of mobile phase pHs for five non steroidal anti-inflammatory drugs (NSAIDs). For comparsion, 
ACD labs software (ACD labs, RSC, UK) based computational logD values were used instead 
of the more traditional logPOW which are only valid for the neutral species (Klein et al., 1988).  
5.2. Theoretical considerations 
 
Retention in reverse phase chromatography for solutes that exhibit acid-base behavior 
depends on the pH of the mobile phase. The relationship between pH and pKa for ionisable 
solutes is well established through Henderson-Hasselbalch equations (Horváth, 1977). The 
degree of ionisation of a given solute is based on the pH of the solution. Arunyanart and Cline-
Love (Arunyanart and Cline Love, 1985) and Rodgers and Khaledi (Rodgers and Khaledi, 
1994) studied the effect of pH on the MLC retention of weak acids and bases. These authors 
derived an equation that describes the observed behaviour in terms of pH and micellar 
concentration. For a monoprotic acid (solutes with one solvated proton H+), the dissociation in 
the mobile phase is governed by the following equilibrium:  
HA   H+ + A¯                  (5.1) 
where A¯  is the dissociated acid and H+ is the solvated proton.  
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For simplicity, solvated proton concentration will be denoted by h in the proceeding 
equations. The equilibrium constant can then be described as: 
�� = [��][�]ℎ                                                                 (5.2) 
where h is the proton concentration and KH is the protonation constant, the capacity factor of a 
chromatographic system can then be represented as:  
݇′ = � [�ௌ]+[��ௌ][�]+[��]+[��]+[���]                                                                                (5.3) 
where [AS] and [A] are the concentrations of the non-protonated species present in the 
stationary phase and the bulk aqueous phase, respectively, and [HAS] and [HA] represent the 
concentrations of the respective acidic species. Lastly, [AM] and [HAM] represent the 
concentrations of the basic and acidic species associated with the micelle, respectively.  
The solute retention in the chromatographic system studied here is assumed to be case 
of several partition equilibria (or reversible association) between dissociated or un-dissociated 
solute, micelles and the stationary phase (García-Alvarez-Coque et al., 1997). This equilibrium 
can be described as: 
(1) Association of the acidic species with the micelle: 
 ܪ� + � ⇋ HAM                   (5.4) 
 ���� = [���][��][�]                                                                                  (5.5) 
(2) Partitioning of the acidic species with the stationary phase: 
           ܪ� ⇋ ܪ�ܵ                      (5.6) 
                         ���ௌ = [��ௌ][��]                                 (5.7) 
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(3) Association of the basic species with the micelle: 
         � + � ⇋ ��                     (5.8) 
        ��� = [��][�][�]                                (5.9) 
(4) Partitioning of the basic species with the stationary phase: 
        � ⇋ �ܵ                               (5.10) 
       ��ௌ = [�ௌ][�]                                (5.11) 
By substituting Eq. (5.2, 5.4 – 5.11) with Eq. 5.3, and changing KAS = ϕPAS and KHAS = ϕPHAS, 
the following Eq. will be obtained: 
][][1' MhKKMKhK
hKKKk
HHAMAMH
HHASAS                 (5.12) 
On rearranging Eq. (5.12): 
 
                                                           (5.13)  
 
where HASK and 
H
AMK are conditional constants with respect to the proton concentration that 
show a sigmoidal dependence with pH.  
Eq. (5.13) can be re-written as follows: 
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Eq. (5.14) has been reported previously (Arunyanart and Cline Love, 1985, Rodgers et al., 
1993) indicating a sigmodal behaviour dependence on pH between the retention of acidic and 
basic species, thus validating the theoretical models. 
5.3. Results and discussion  
 
Generally, all previous studies have considered octadecylsilyl (ODS) bonded columns 
to establish retention-surfactant-pH relationships for the organic acids and bases (García-
Alvarez-Coque et al., 1997; Torres-Lapasió et al., 2000; Ruiz-Angel et al., 2004; Pous-Torres 
et al., 2009). However, Aryunyanart and Cline Love (1985) have shown a comparison between 
ODS and CN bonded columns in relation to the retention of some organic acids and bases with 
respect to surfactant concentration and pH of the mobile phase. Retention of solutes on ODS 
and CN based columns differ in terms of surfactnat adsorption capacity. ODS columns do 
adsorb SDS surfactant monomers with the negative head group in contact with the mobile 
phase, such that the surface is charged and will repulse anionic species. On the other hand, CN 
based columns tend to adsorb a negligible amount of surfactant monomers, thus, presenting a 
higher capacity of retaining anioinc species (Arunyanart and Cline Love, 1985).  
This study investigates the retention and paritioning behaviour of five structurally 
related hydrophobic drugs (NSAIDs) with reference to the mobile phase pH. Some of the 
relevant physicochemical properties including the dissociation constant (pKa) and octanol-
water partitioin coefficients (logPOW) are presented in Table 3.1. Since cyano bonded columns 
only function over a narrow pH range (2-8), it was vital to select a pH range that does not 
produce any drastic effects on the column. It was decided that a pH range of 3-7 would be 
sufficient to elicit various ionisation levels of drugs and also corresponds to physiological 
conditions. The aqueous pKa for all studied drugs is from 4.1 to 4.5 (Waters et al., 2012), 
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therefore, it was expected that various percentages of ionic species would exist at the studied 
range of mobile phase pH.  
5.3.1. Retention and pH relationship 
 
Theroretically, application of the models described in Section 5.2 should produce a 
sigmoidal behaviour in the studied range of pH (i.e. 3 - 7). However, deviations from the 
theoretical outcomes were achieved and no sigmoidal behaviour was obtained when capacity 
factors were plotted against pH over a range of surfactant concentrations as presented in 
Figures 5.1 – 5.5. Arunyanart and Cline Love (1985) reported that the pH of the mobile phase 
has significant importance on the retention of monoprotic acids. They found that at low pH 
values the neutral acid k’ values decrease, and at high pH the anionic conjugate bases k’ values 
increase with increasing SDS concentration on an ODS stationary phase. However, the 
opposite of what has previously been reported (Arunyanart and Cline Love, 1985) was seen in 
this study, i.e. anionic conjugate bases k’ values were decreased with increasing SDS 
concentration (Figure 5.1 – 5.5). The fact is ODS columns tend to adsorb more anionic 
surfactant than cyano-bonded stationary phases, therefore, the elution behaviour versus pH for 
weak acids on cyano columns would be the opposite to that observed in ODS columns. 
 
The separation process in micellar liquid chromatography for neutral species is mainly 
controlled by the hydrophobic intractions of the compound with the micellar system and the 
stationary phase (Arunyanart and Cline Love, 1985). However, electrostaic attraction, or 
replusion, affects the retention behaviour for ionised species. This behaviour was evident in 
this study where neutral species show a high affinity for the micellar hydrophoic core through 
hydrophobic interactions, thus eluted quickly. Once the pH of the mobile phase was raised 
above the pKa of each drug, negatively charged species were electrostatically repelled from the 
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micelle thus interaction with the stationary phase was increased. This resulted in delayed 
elution of the drugs from the column which is confirmed from high capacity factor values 
(Figures 5.1 – 5.5). Overall, a similar trend with a comparable retention on the stationary phase 
was seen for all the drugs studied here. This is because of the similar ionisation constants and 
the hydrohobicity of these compounds. 
 
 
Figure 5.1: Plot of capacity factors of ibuprofen at various mobile phase pHs 
 
 
 
Figure 5.2: Plot of capacity factors of ketoprofen at various mobile phase pHs 
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Figure 5.3: Plot of capacity factors of flurbiprofen at various mobile phase pHs 
 
 
 
 
 
Figure 5.4: Plot of capacity factors of fenbufen at various mobile phase pHs 
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Figure 5.5: Plot of capacity factors of fenoprofen at various mobile phase pHs 
 
 
5.3.2. Partition and ionisation relationship 
 
The extent of ionisation for each compound at a pH range of 3-7 was calculated using 
the Henderson-Hesselbalch relationship for monoprotic weak acids as given by Eq. (5.15): 
   10010110%   aapKpHpKpHionisation                  (5.15) 
 
Table 5.1 shows the percent ionisation of the five drugs at six different pH values of 
the mobile phase. The lowest ionisation was observed at pH 3 which is lower than the pKa of 
all drugs and the drugs are predominantly in their non-ionised form. At pH values above the 
pKa,  an anionic form of the drugs dominates.  
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Table 5.1: Percent ionisation of five drugs at six different pH values 
Drug pKa 
% ionisation at various pH 
3 4 5 5.8 6.4 7 
Ibuprofen 4.41 3.74 28.01 79.55 96.09 98.99 99.74 
Ketoprofen 4.23 5.56 37.06 85.48 97.38 99.33 99.83 
Flurbiprofen 4.14 6.76 42.01 87.87 97.86 99.45 99.86 
Fenbufen 4.55 2.74 21.99 73.81 94.68 98.61 99.65 
Fenoprofen 4.20 5.94 38.69 86.32 97.55 99.37 99.84 
 
In theory, the anionic form of a drug should experience electrostatic repulsion from the 
anionic micelles, therefore, will be retained on the stationary phase longer than in its non-
ionised form. Attempts were made to correlate the retention behaviour of compunds in the 
chromatographic system, in terms of the micelle-water partition coefficients, with 
corresponding percent ionisation and computational logD values over a range of pHs of the 
mobile phase as presented in Figures 5.6 – 5.10. As can be seen from these figures a significant 
decrease in the logPMW was achieved at a pH above the pKa of the compounds. This is because 
the compounds studied were mainly in their neutral form at a pH below their dissociation 
constants and have relatively more affinity for the hydrophobic core of the micelle than the 
bulk aqueous phase. As the pH was increased above the dissociation constant, the compounds 
were ionised to a greater extent and therefore more soluble in the bulk aqueous phase rather 
than the hydrophobic core of the micelle. Another reason for this was the electrostatic repulsive 
forces driving the anionic species of the drugs away from the micelles. As a result, relatively 
higher retention times were achieved for the ionised form of the drugs because of an increased 
affinity for the bulk aqueous phase and, consequently, for the cyano-bonded stationary phase.  
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Figure 5.6: Relationship of logPMW, logD and % ionisation of ibuprofen 
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Figure 5.7: Relationship of logPMW, logD and % ionisation of ketoprofen 
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Figure 5.8: Relationship of logPMW, logD and % ionisation of flurbiprofen 
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Figure 5.9: Relationship of logPMW, logD and % ionisation of fenbufen 
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Figure 5.10: Relationship of logPMW, logD and % ionisation of fenoprofen 
 
 
5.3.3. LogPMW and logD relationship 
 
The traditional approach of describing partitioning, namely the octanol-water partition 
coefficient does not account for the ionised species (Klein et al., 1988), therefore, 
computational logD values were obtained from the ACD i-Lab software (RSC, UK). This was 
achieved by carefully analysing and mapping the logD vs. pH graphs for each drug at specified 
pH values used in this study. Table 5.2 shows logPMW and logD values while Figures 5.11 and 
5.12 illustrate the logPMW and logD values at six different pH values of the mobile phase. 
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Table 5.2: Effect of mobile phase pH on experimentally determined logPMW values compared with calculated logD values for five drugs 
Drug 
pH 3.0 pH 4.0 pH 5.0 pH 5.8 pH 6.4 pH 7.0 
logPMW logD logPMW logD logPMW logD logPMW logD logPMW logD logPMW logD 
Fenbufen 2.20 3.1 2.05 3.0 2.01 2.5 1.73 1.8 1.58 1.3 1.31 0.7 
Fenoprofen 2.25 3.7 1.98 3.5 1.85 2.9 1.38 2.1 1.04 1.6 0.52 1.0 
Flurbiprofen 2.20 3.6 2.04 3.4 1.92 2.7 1.45 2.3 1.11 1.3 0.39 0.8 
Ibuprofen 2.14 3.5 2.04 3.4 1.98 2.8 1.47 2.2 1.22 1.4 0.21 0.9 
Ketoprofen 2.13 2.9 2.04 2.7 1.82 2.1 1.23 1.3 0.99 0.9 0.42 0.2 
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Figure 5.11: LogPMW of five drugs at various mobile phase pH values 
 
 
 
 
 
Figure 5.12: ACD software calculated logD values of five drugs at various pH values 
 
The data suggest that the log D is a reasonable predictor of the MLC derived 
partitioning values across the range of drugs studied.  While absolute values of logD and 
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logPMW significantly differ (Table 5.2), the change in both values with respect to pH is 
consistent from pH 5 to 7. Interestingly while the relationship between the measured logPMW 
and pH shows deviation from linearity around the pKa’s of the drug substance, the calculated 
logD values are better correlated with pH across the entire range of pH studied. This may 
suggest either an oversimplification of the calculational approach to ionisation or enhanced 
sensitivity of the MLC technique in reporting partitioning data near the pKa of the analyte in 
the experimental solvent system. 
This relationship is further explained on the basis of correlation between experimental 
and computational values. The micelle-water partition coefficient (logPMW) values at different 
mobile phase pH were linearly regressed against computational logD values at similar pH 
conditions (Figures 5.13 – 5.17) using Origin software version 8.5 (Northampton, USA). Two 
parameters, namely R2 and Pearson’s correlation coefficient were assessed in order to explain 
the correlation between logPMW and logD values. The Pearson’s correlation coefficient is a 
numerical measure of the strength of the relationship between two random variables (Pearson, 
1901). The value of the correlation coefficient varies from -1 to 1. A positive value means that 
the two variables under consideration have a positive linear relationship (i.e., an increase in 
one corresponds to an increase in the other) and are said to be positively correlated. A negative 
value indicates that the variables considered have a negative linear relationship (i.e., an increase 
in one corresponds to a decrease in the other) and are said to be negatively correlated. The 
closer the value is to +1 or -1, the stronger the degree of linear dependence. The R2 values for 
ibuprofen, ketoprofen, flurbiprofen, fenbufen and fenoprofen were found to be 0.943, 0.963, 
0.962, 0.974 and 0.954, respectively. Pearson’s correlation coefficients were found to be in the 
range of 0.945-0.987. These values show a good correlation between the chromatographic 
partition coefficients and the computational values despite the fact there are mechanistic 
differences between the two techniques. 
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Figure 5.13: LogPMW and logD relationship for ibuprofen 
 
 
 
 
 
Figure 5.14: LogPMW and logD relationship for ketoprofen 
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Figure 5.15: LogPMW and logD relationship for flurbiprofen 
 
 
 
 
 
Figure 5.16: LogPMW and logD relationship for fenbufen 
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Figure 5.17: LogPMW and logD relationship for fenoprofen 
 
 
5.4. Conclusions 
 
It can be seen that for the five drugs under investigation in this study the pH of the 
mobile phase significantly influenced the partitioning behaviour observed using MLC. In 
particular, a strong correlation of logPMW was observed with calculated logD values. More 
interestingly, a significant change in partitioning was observed near the pKa of each drug 
indicating an influence of ionised species on the association with the micelle and retention on 
the stationary phase.  
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Chapter 6: Effect of elevated column temperatures on 
the partitioning of compounds 
 
1This chapter deals with the effects of elevated column temperatures on the partitioning of 
seven compounds of different ionic nature using micellar liquid chromatography (MLC). A 
series of column temperatures (295 K – 317 K) were selected with the aim to evaluate the 
possible thermodynamic parameters involved in the partitioning of these drugs.  
 
6.1. Introduction 
 
Chromatographic retention in conventional HPLC has been described in terms of 
thermodynamics properties (Melander et al., 1968; Colin et al., 1978). The thermodynamic 
theory has satisfactorily accounted for the interactions of the solute with the mobile phase and 
the stationary phase. Melander and coworkers applied the van’t Hoff equation to reverse phase 
chromatography as described in Eq. (6.1) (Melander et al., 1968): ݈݊݇′ = − ∆�ோ் + ∆ௌோ + ݈݊�                                                                                   (6.1) 
where k’ is the capacity factor, R is the gas constant, T is the temperature in Kelvin and φ is the 
volume phase ratio. 
The resultant van’t Hoff plots give enthalpies and entropies of transfer of the solute from 
the mobile phase to the stationary phase. Since micellar liquid chromatography is a form of 
reverse phase HPLC, the effect of temperature on retention may provide information 
concerning the thermodynamics of the partitioning of compounds in micellar chromatographic 
processes. However, the use of thermodynamic properties in describing micellar liquid 
chromatography has been limited. Dorsey and coworkers directly applied Eq. (6.1) to describe 
                                                          
1
 Sections of this chapter have been published, see Appendix A 
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the thermodynamics of the partitioning in micellar liquid chromatography (Dorsey et al., 1983). 
More recently, Waters and coworkers (2007) have explained the thermodynamic function of 
the transfer of solutes from one phase to another phase which can lead to the determination of 
a change in the Gibbs free energy (ΔG).  ∆ܩ = −ܴ݈ܶ݊PMW                                                                                                       (6.2) 
where R is the gas constant (8.314 J.K-1.mol-1) and T is the temperature in Kelvin at which the 
partitioning process occurred. 
Partitioning is a thermodynamic process and determination of whether a micelle-solute 
interaction at equilibrium is enthalpy- and/or entropy-driven can be achieved by 
thermodynamic analysis. An enthalpy-driven process is usually associated with the formation 
of new bonds such as hydrogen bonds and van der Waals interactions, whereas an entropy-
driven process is usually characterised by the displacement of ordered water molecules coupled 
with the formation of new hydrophobic interactions (Leffler, 1963; Kim, 2001). Previous 
studies have shown that application of the van’t Hoff isochore on partitioning data over a range 
of temperatures can facilitate calculation of the change in enthalpy (ΔH) and entropy (ΔS) of 
the system (Congliang et al., 2007; Waters et al., 2007) .  
This work presents partitioning of a range of pharmaceutical compounds at a series of 
elevated column temperatures in an attempt to investigate the thermodynamics of the 
partitioning process, especially with reference to physicochemical characteristics of 
compounds.  This will be achieved by selecting pharmaceutical compounds of different ionic 
states in solution i.e. anionic (fenbufen, fenoprofen, flurbiprofen, ibuprofen and ketoprofen), 
cationic (procaine) and neutral (paracetamol). 
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6.2. Results and discussion 
 
Temperature has a major impact on retention, selectivity, and resolution in 
chromatographic separations (Oberleitner et al., 2002). In chromatographic systems, the 
distribution coefficient of a solute between the mobile phase and stationary phase is a function 
of the difference in free energy of the solute in the two phases (Martin, 1949). Thus, a better 
understanding of the partition mechanism of a solute between micellar pseudophase and 
stationary phase is important to control selectivity.  
 Chromatographic retention of various solutes was determined at a range of elevated 
column temperatures (i.e. from 295 K to 317 K) using micellar mobile phase. From the linear 
relationship of the inverse of capacity factors (1/k’) and the micellar concentration (CM), 
micelle water partition coefficients were deduced at each studied temperature. The influence 
of temperature on the retention of seven solutes considered in this work is presented in Figures 
6.1 to 6.7. 
 
Figure 6.1: Plots of inverse of the capacity factors vs. micellar concentration for fenbufen at 
various temperatures 
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Figure 6.2: Plots of inverse of the capacity factors vs. micellar concentration for fenoprofen 
at various temperatures 
 
 
 
 
Figure 6.3: Plots of inverse of the capacity factors vs. micellar concentration for flurbiprofen 
at various temperatures 
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Figure 6.4: Plots of inverse of the capacity factors vs. micellar concentration for ibuprofen at 
various temperatures 
 
 
 
 
 
Figure 6.5: Plots of inverse of the capacity factors vs. micellar concentration for ketoprofen 
at various temperatures 
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Figure 6.6: Plots of inverse of the capacity factors vs. micellar concentration for paracetamol 
at various temperatures 
 
 
Figure 6.7: Plots of inverse of the capacity factors vs. micellar concentration for procaine at 
various temperatures 
Table 6.1 represents the micelle-water partition coefficients at each studied temperature 
along with the slopes and intercepts of the linear relationships of 1/k’ vs. CM. 
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Table 6.1: Partition coefficient measurement at various column temperatures
Drugs Temp./K Slope Intercept R2 PMW LogPMW 
Fenbufen 
295 32.1 0.24 0.992 133.8 2.13 
298 105.4 0.82 0.999 128.5 2.11 
305 113.3 0.85 0.998 133.3 2.12 
310 119.8 0.80 0.996 149.8 2.18 
317 118.6 0.74 0.999 160.3 2.20 
Fenoprofen 
295 33.3 0.35 0.997 95.1 1.98 
298 116.4 1.00 0.998 116.4 2.07 
305 115.5 1.18 0.976 97.9 1.99 
310 111.0 1.14 0.984 97.4 1.99 
317 122.0 0.98 0.992 124.5 2.10 
Flurbiprofen 
295 38.5 0.35 0.999 110.0 2.04 
298 137.5 1.12 0.992 122.8 2.09 
305 135.8 1.14 0.992 119.1 2.08 
310 158.2 1.05 0.996 150.7 2.18 
317 152.3 0.93 0.953 163.8 2.21 
Ibuprofen 
295 47.7 0.43 0.999 110.9 2.04 
298 115.5 1.69 0.991 68.3 1.83 
305 165.4 1.37 0.998 120.7 2.08 
310 172.3 1.36 0.978 126.7 2.10 
317 186.6 1.28 0.996 145.8 2.16 
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Table 6.1: continued….
Drugs Temp./K Slope Intercept R2 PMW LogPMW 
Ketoprofen 
295 22.3 0.20 0.999 111.5 2.05 
298 47.4 0.62 1.000 76.5 1.88 
305 54.8 0.59 0.989 92.9 1.97 
310 61.3 0.60 0.998 102.2 2.01 
317 58.7 0.61 0.999 96.2 1.98 
Paracetamol 
295 12.4 1.24 0.997 10.0 1.00 
298 11.9 1.19 0.985 10.0 1.00 
305 10.7 1.22 0.996 8.8 0.94 
310 10.2 1.28 0.982 7.9 0.90 
317 9.73 1.30 0.992 7.5 0.87 
Procaine 
295 284.5 0.84 0.832 338.7 2.53 
298 345.7 1.65 0.911 209.5 2.32 
305 518.5 2.38 0.985 217.9 2.34 
310 523.7 2.73 0.947 191.8 2.28 
317 536.0 3.28 0.923 163.4 2.21 
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Figure 6.8 represents slopes obtained from the plots of 1/k’ vs. CM for five drugs, 
namely fenbufen, fenoprofen, flurbiprofen, ibuprofen and ketoprofen at five different column 
temperatures. An increase in column temperature does increase the slope, however, a clear 
correlation was not observed in the case of fenoprofen and flurbiprofen. In fact, these drugs 
have shown a more complex behaviour at elevated column temperatures. On the contrary, 
slopes for fenbufen, ibuprofen and ketoprofen either remained almost unchanged above 298 K, 
or increased as seen in the case of ibuprofen. A more general perception could be taken from 
these relationships that, more or less, a slight increase in slope was seen in all cases above 298 
K.  
 
 
Previously it was reported that an increase in the slope or intercept with respect to 
column temperature generally represents preference of a solute for the bulk aqueous phase over 
micellar pseudophase (Tomasella and Love, 1990). Taking into consideration this fact, an 
increase in the slope values obtained here would mean that anionic drugs considered in this 
0
40
80
120
160
200
240
290 295 300 305 310 315 320
Sl
o
pe
Temperature/K
Fenbufen Fenoprofen Flurbiprofen Ibuprofen Ketoprofen
Figure 6.8: Comparison of slopes obtained from 1/k’ vs. CM plots for five anionic drugs 
over a range of temperatures 
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study favoured the bulk aqueous phase at the studied range of column temperatures. If this was 
true, longer retention times would be achieved at elevated temperatures because of the fact that 
more the drug in the bulk aqueous phase, the more is available to interact with the cyanopropyl 
based stationary phase and less contribute to the micelle-water partition coefficient. On the 
contrary, a decrease in retention time of five anionic drugs was recorded which shows 
preference of these drugs for the micellar pseudophase. In line with the findings described in 
Chapter 3, adsorption of SDS on cyanopropyl columns is far less than the conventional ODS 
columns (C1, C8 and C18) (Berthod et al., 1986), therefore, justifying the outcomes of this 
study. The retention mechanism at ambient temperature (295 K) was quite different from that 
seen at elevated column temperatures. Longer retention times were seen at an ambient 
temperature, which showed preference for the bulk aqueous phase. These results are 
graphically illustrated in Figures 6.1 – 6.5. 
 
 
 
 
 
 
Paracetamol, a neutral drug, interacted differently with the micelles and the cyano bonded 
stationary phase. An increase in column temperature had almost no effect on the retention of 
this drug with a slight decrease in the slope values. A slight decrease in partition coefficient 
(see Table 6.1) at an elevated column temperature shows a preference of paracetamol for the 
bulk aqueous phase. In the case of the cationic drug, procaine, results obtained in this study 
(A) (B) 
Figure 6.9: Slopes obtained from 1/k’ vs. CM plots for paracetamol (A) and procaine (B) over 
a range of temperatures 
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were in line with those previously reported where an increase in slope (Figure 6.9 B) showed 
a preference for the bulk aqueous phase (Tomasella and Love, 1990). At an elevated column 
temperature, procaine showed slightly higher affinity for the bulk aqueous phase which resulted 
in a marginal decrease in the partition coefficient (Table 6.1). 
One of the objectives of this study was to evaluate thermodynamic parameters including 
the change in free energy (ΔG), enthalpy (ΔH) and entropy (ΔS) values as the solutes transfer 
from the bulk aqueous phase to the micellar pseudophase as a function of temperature. Under 
linear chromatographic conditions, the temperature dependence of the partition coefficient of 
a given solute can be expressed by replacing k’ with P in the van’t Hoff equation (6.1) (Coym 
and Dorsey, 2004): ݈݊P = − ∆�ோ் + ∆ௌோ + ݈݊�                                                                                               (6.3) 
where P  is the partition coefficient of a solute between the two phases, ΔH and ΔS are the 
enthalpy and entropy change associated with the transfer of solute from one phase to another, 
R is the gas constant, T is the temperature, and φ is the volume phase ratio, which is the ratio 
of volume of stationary phase to the volume of mobile phase. Berthod and coworkers observed 
that the adsorbed surfactant on the bonded phase remains constant with micellar mobile phases 
(Berthod et al., 1986). Therefore, the volume phase ratio (φ) would remain constant and can be 
neglected from Eq. (6.3). Thus, the slope of the plot between the natural logarithm of PMW and 
1/T would give the enthalpy of solute transfer as given by the following equations (Tomasella 
and Love, 1990): 
݈ܵ݋݌� = − ∆�ோ                                                                                                                        (6.4) 
and ܫ݊�����݌� = ∆ௌோ                                                                                                     (6.5) 
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A distinct nonlinearity in van’t Hoff plots was observed when the inverse of the 
temperature (1/T) was plotted against the natural logarithm of micelle-water partition 
coefficient (lnPMW) as shown in Figure 6.10. Nonlinear van’t Hoff plots indicate a temperature 
dependence of the partitioning of drugs from bulk aqueous phase to the micellar pseudophase.  
 
 
 
 
 
 
 
 
 
Figure 6.10: van’t Hoff plots for five drugs at 295 K, 298 K, 305 K, 310 K and 317 K 
 
However, an improved linearity was achieved when two data points (298K and 305 K) 
were excluded and lnPMW was plotted at three temperatures (295 K, 310 K and 317 K) which 
led to the calculation of thermodynamic parameters of interest. Figures 6.11 – 6.16 are 
graphical representations of the van’t Hoff plots at various temperatures. 
0.00315 0.00320 0.00325 0.00330 0.00335 0.00340
4.70
4.75
4.80
4.85
4.90
4.95
5.00
0.00315 0.00320 0.00325 0.00330 0.00335 0.00340
4.3
4.4
4.5
4.6
4.7
4.8
0.00315 0.00320 0.00325 0.00330 0.00335 0.00340
4.6
4.7
4.8
4.9
5.0
5.1
5.2
0.00315 0.00320 0.00325 0.00330 0.00335 0.00340
4.85
4.90
4.95
5.00
5.05
5.10
0.00315 0.00320 0.00325 0.00330 0.00335 0.00340
4.55
4.60
4.65
4.70
4.75
4.80
4.85
Ibuprofen
ln
P M
W
1/T (K-1)
Ketoprofen
ln
P M
W
1/T (K-1)
Flurbiprofen
ln
P M
W
1/T (K-1)
Fenbufen
ln
P M
W
1/T (K-1)
Fenoprofen
ln
P M
W
1/T (K-1)
 
122 
 
Figure 6.11: van’t Hoff plot for fenbufen at 295 K, 310 K and 317 K 
 
 
 
Figure 6.12: van’t Hoff plot for flurbiprofen at 295 K, 310 K and 317 K 
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Figure 6.13: van’t Hoff plot for ibuprofen at 295 K, 310 K and 317 K 
 
 
 
Figure 6.14: van’t Hoff plot for ketoprofen at 295 K, 310 K and 317 K 
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Figure 6.15: van’t Hoff plot for paracetamol at 295 K, 310 K and 317 K 
 
 
 
 
 
Figure 6.16: van’t Hoff plot for procaine at 295 K, 310 K and 317 K 
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these compounds from the bulk aqueous phase to the micellar pseudophase was 
thermodynamically favoured. Since the van’t Hoff plots were presumably independent of the 
phase ratio (φ), the linearity would suggest a constant enthalpy of transfer from the bulk 
aqueous phase to the micellar pseudophase at three temperatures (295 K, 310 K and 317 K). 
Higher values of the change in enthalpy (ΔH) as compared to entropy (ΔS) suggest that the 
partitioning process was enthalpically driven. Fenbufen, flurbiprofen and ibuprofen showed 
positive enthalpies which were attributed to a less hydrophobic interaction with the stationary 
phase as these solutes were largely in the core of the micelles (Lee and Hoffman, 1994). 
However, negative enthalpy values of ketoprofen, paracetamol and procaine demonstrated 
hydrophobic interactions with the stationary phase because of an increasing preference for the 
bulk aqueous phase for these compounds. 
 
 
Table 6.2: Change in Gibbs free energy (ΔG), enthalpy (ΔH) and entropy (ΔS) of various 
compounds 
Drugs ΔG (kJ. mol-1) ΔH (kJ. mol-1) ΔS (kJ. mol-1. K-1) 
Fenbufen -12.77 ± 0.69  6.42 ±  0.79 0.062 ± 0.001 
Flurbiprofen -12.42 ± 0.81 14.73 ± 2.30 0.089 ± 0.009 
Ibuprofen -12.80 ± 0.70 9.38 ±  1.19 0.071 ± 0.007 
Ketoprofen -11.55 ± 0.45 -5.20 ± 0.61 0.022 ± 0.002 
Paracetamol   -5.43 ± 0.19 -12.87 ± 1.39 -0.024 ± 0.009 
Procaine -14.64 ± 0.63 -29.88 ± 2.79 -0.052 ± 0.009 
 
 
Previous studies have demonstrated that a significant amount of water is present in 
palisade and stern layers of conventional micelles (El Seoud, 1997; Mukerjee and Ko, 1992). 
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The chemistry on, and around, the surface of the micelle is influenced through the water 
molecules residing in the palisade and stern layers of the micelle. It has been suggested that 
these water molecules can influence the polarity and the hydrogen bonding character of the 
micelle (Mukerjee and Ko, 1992; Poole and Poole, 1997). Additionally, all the compounds 
have hydrogen bond donating and/or hydrogen bond accepting functional groups on the 
molecules, hydrogen bonding is believed to play a more significant role than the hydrophobic 
interaction (Akbay et al., 2007). Therefore, the chemistry on, and around, the micellar surface 
can be altered by temperature. An increase in temperature may increase the ionisation of the 
water molecules as well as of the compounds, thus the interactions between the micelles, 
stationary phases and the solutes can be significantly influenced by temperature. 
 
The entropy values were negative for paracetamol and procaine which shows their 
preference for the aqueous phase. In contrast, positive entropy values were obtained for anionic 
drugs, namely fenbufen, flurbiprofen, ibuprofen and ketoprofen. This can be attributed to the 
contribution from hydrophobic interactions between the solutes and the micellar pseudophase. 
It is reasoned that the presence of a hydrophobic solute forces the water molecules surrounding 
the solute to form a dense, ordered network of hydrogen bonds with each other to minimise 
their contact with the hydrophobic solute within the palisade or stern layer of the micelle, 
thereby, lowering the total entropy of the aqueous system. This ordered network of water 
molecules will disappear upon transfer of hydrophobic solutes from the polar aqueous solution 
into the relatively hydrophobic stationary phase. Consequently, the total entropy of the system 
increases for anionic drugs compared with neutral (paracetamol) and cationic (procaine) drugs. 
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6.3. Conclusions 
 
This study evaluates the impact of elevated column temperature on the partitioning of 
compounds of varying physicochemical properties. This allowed determination of 
thermodynamic parameters involved in the partitioning process. Negative ΔG values indicated 
partitioning as a spontaneous exothermic process. The partitioning of seven drugs considered 
in this study were enthalpically driven with a small change in the entropy (ΔS) of the system 
which was possibly because of the change in the nature of hydrogen bonding of water at 
elevated temperatures and the hydrophobic interactions presented by the drugs and the micelle. 
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Chapter 7: Modeling skin permeability with micellar 
liquid chromatography 
 
 
*Previous chapters described MLC based micelle-water partition coefficients as a potential 
alternative to the traditional octanol – water method. This chapter highlights the practical 
applicability of this newly developed system in a more real world scenario. The data acquired 
using MLC will be used in developing a quantitative relationship with human skin permeability 
and other physicochemical properties of commonly used pharmaceutical compounds. The 
derived relationship will then be compared with the established quantitative relationships 
which are built upon the traditional octanol-water partition coefficients. 
 
 
7.1. Introduction 
 
The skin, together with the mucosal linings of the digestive and respiratory tract, is the 
largest organ of the human body and protects the internal body structure from external hostility 
such as micro-organism entry, radiation as well as limiting water loss from the body (Meidan, 
1996; Silva et al., 2012). Transdermal delivery of pharmaceutical compounds has remained a 
challenging domain for pharmaceutical scientists over the years. Generally, it was assumed that 
skin is impermeable to pharmaceutical compounds especially ionic species (Sun et al., 2008). 
However, with an advancement in understanding the structural properties of skin, penetration 
of various ionic compounds has been documented in the 1950’s and 1960’s (Blank et al., 1957; 
Malkinson, 1958; Stoughton et al., 1960; Stoughton, 1962).  
The skin consists of three major layers: the epidermis, the dermis and subcutaneous fat 
or hypodermis (Figure 7.1). The epidermis is the outermost layer of the skin which is 
                                                          
*
 Sections of this chapter have been published, see Appendix A 
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characterised as the thinnest part of the skin and its thickness varies depending upon the 
location of the skin. It is further divided into 5 distinct layers: the stratum corneum or horny 
layer; the stratum lucidum; the stratum granulosum; the stratum spinosum; and the stratum 
basale. The stratum corneum is composed of compact, dehydrated and keratinised multi-
layered cells that are embedded in a matrix of lipid lamellas that descend from the secreted 
content of the lamellar bodies, which gives the stratum corneum a brick and mortar organisation 
(Moss et al., 2002). Although it is the thinnest and smallest compartment of the skin it 
represents the main barrier function of the skin (Barry, 1983).  
 
Figure 7.1: Structure of the skin (Barry, 1983) 
 
The dermis is connected by the basement membrane to the stratum basale. This junction 
is of folded appearance, supporting the exchange of nutrients and other physiological 
substances with the unvascularised epidermis. The main components of the dermis are collagen 
and elastin fibers that form a vast network of filamentous and amorphous connective tissue that 
provides strength and flexibility to the skin (Schaefer and Redelmaier, 1996). Furthermore, the 
dermis accommodates cellular residents such as fibroblasts, endothelial cells, mast cells and, 
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under conditions of inflammation, macrophages, lymphocytes and leucocytes. The tissue of the 
dermis has an extensive vascular network that is involved in nutrition, thermal regulation and 
immune responses. A variety of appendages, such as hair follicles or sweat and sebaceous 
glands are also derived from this tissue. Underneath the dermis is the hypodermis that contains 
subcutaneous fats which represent a source of energy for the body. It provides support and 
mechanical cushioning for the overlying skin. It also acts as a thermal insulator and a shock 
absorber (Moss et al., 2002). 
In recent years, skin has been extensively studied as an alternative route for drug 
delivery. Transdermal drug delivery facilitates the passage of a drug substance through the skin 
into the general circulation where it can have systemic effects, thus bypassing the hepatic first-
pass effect. This route offers several other advantages over the oral route; for example, 
avoidance of untoward gastro-intestinal effects, controlled drug release over a long period of 
time and patient compliance (Shahzad et al., 2012; Silva et al., 2012). 
7.2. Modelling skin permeation 
 
An ideal situation for a pharmaceutical research and development setup is to predict the 
percutaneous absorption of a potential drug candidate from its physicochemical and structural 
properties. This is important because thousands of new compounds (which could be potential 
drug candidates) are being synthesised and extensively tested through various in vitro and in 
vivo models. However, these initial measurements can take a long time and face a series of 
ethical, economical and legislative difficulties; for example, ethical approval is required when 
animals or humans are involved in the experiments and there is increasing legislation in the 
risk assessment of industrial chemicals (Martínez-Pla et al., 2003; Moss et al., 2009; Chen et 
al., 2010). To overcome these difficulties, several mathematical models have been proposed to 
predict skin permeability of compounds from their structural parameters (Potts and Guy, 1992; 
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Potts and Guy, 1995; Lien and Gao, 1995; Barratt, 1995b; Abraham et al., 1995a; Abraham et 
al., 1997). These mathematical models are based on quantitative structure-permeability 
relationships (QSPR) correlating experimental skin permeability to physicochemical properties 
such as an octanol – water partition coefficient (logP), molecular weight (MW), melting point 
(MP), molecular volume (MV), hydrogen bond donor and acceptor, polarity and other 
molecular structure descriptors.  
The quantitative structure-permeability relationships not only help in understanding the 
science behind skin permeation but also provide an invaluable help in analysing the data that 
results from the mechanistic studies of skin permeation. Developing a QSPR usually occurs in 
three distinct steps: 
1. Gathering biologically relevant data 
The foremost and the most important part in any QSPR development is to acquire a set 
of biological relevant data that has been obtained during real time in vitro or clinical 
investigations. The quality, applicability and predictability of QSPR rely upon the source data.  
2. Gathering physicochemical properties and molecular descriptors 
With respect to skin permeation, QSPR model development is often dependent on the 
physicochemical properties and/or structural and molecular descriptors of a permeant. Some of 
the important and routinely used physicochemical and molecular properties are: 
A. Lipophilicity 
Lipophilicity is the single most informative physicochemical property in 
medicinal chemistry and also a meaningful parameter in quantitative structure-activity 
relationships (QSARs) (Geinoz et al., 2004), for example prediction of skin 
permeability (Tayar et al., 1991).  
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B. Molecular size 
Molecular size, either in terms of molecular weight (MW) or molecular volume 
(MV), plays a distinct role in membrane permeation (Xiang and Anderson, 1994, Bunge 
and Cleek, 1995). Generally speaking, in simple liquid systems, drug diffusivity (Di) is 
inversely dependent on the size of the permeant whilst an exponential relationship 
exists in organised media such as polymers and the stratum corneum (Kasting, 1987). 
This relationship can be expressed mathematically by Eq. (7.1): 
)(MVB
i eDD
                     (7.1) 
Where Do is the diffusivity of a hypothetical molecule having zero molecular 
volume, and B is a constant. This implies that drug diffusivity across the stratum 
corneum decreases with an increase in MV or MW, as both of these are interdependent.  
C. Solvatochromic parameters 
A linear solvation free-energy relationship (LSER) is the most widely used 
QSPR approach applied to develop reliable predictive models (Kamlet and Taft, 1976; 
Taft and Kamlet, 1976; Taft et al., 1985). These predictive models are based on 
molecular descriptors that are fundamental in predicting molecular properties in the 
areas of practical and academic interest. These descriptors may be experimentally 
determined properties or theoretically derived quantities (Panayiotou, 2012). LSER 
correlates a given molecular property (SP), for example partitioning, retention, or 
permeation (Pagliara et al., 1997; Pagliara et al., 1995; Abraham et al., 1994) with the 
solvatochromic parameters as follows: 
 
cbapVvS wP   ..*..log                   (7.2) 
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Where v, p, a, and b are the regression coefficients while c is a constant that 
includes the information on the analysed system. Vw is van der Waals volume, π* is 
dipolarity/polarisability, α and β are the hydrogen-bond donor acidity and hydrogen-
bond acceptor basicity, respectively. 
It should be noted that Eq. 7.2 deals with the process that includes only neutral 
solutes. More recently, Abraham and Acree have explained the importance of ionic 
species in LSER analysis (Abraham and Acree Jr, 2010a) and they have incorporated 
additional terms that refer to ion-solvent interactions for cations and anions i.e.  j+j+ for 
cations and j-j- for anions, as shown in Eq. (7.3): 
  jjjjcbapVvS wP  ..*..log                (7.3) 
The improved LSER model (with the addition of ionic species) has proven to 
be a better predictive model for the partition of solutes in water/organic solvents 
(Abraham and Zhao, 2005; Abraham and Acree Jr, 2010b) and in water/liposome 
systems (Zhang et al., 2011) as well as permeation through the blood-brain-barrier 
(Abraham, 2011).     
D. Other molecular properties 
In addition to the above mentioned properties, there are few other parameters that 
have been used in developing QSPR. For example the solubility parameter (SP), polar 
surface area (PSA) (which is directly related to the hydrogen bonding of the solute with the 
solvent) and melting points (MP) of the solutes have been documented (Sloan et al., 1986; 
Riviere and Brooks, 2005). The solubility parameter is related to the solubility of a 
permeant in the stratum corneum of the skin. A molecule that is highly soluble in the 
stratum corneum might not be soluble in other layers of the skin; hence it might have limited 
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skin permeation. Therefore, the use of SP will provide an indication of lipophilic 
compounds likely to exhibit this behaviour (Sun et al., 2008). 
3. Modeling techniques 
The final step in developing a QSPR model is the technique or method used to create a 
link between experimental or clinical data of a series of compounds and their physicochemical 
properties and/or molecular and structural descriptors. This is usually achieved by employing 
a range of statistical and mathematical techniques including multiple linear regression analysis, 
multiple non-linear regression analysis, least squares analysis, neural network algorithms and 
Gaussian algorithms (Livingstone, 1995). 
7.3. Methodology 
7.3.1. Data mining and generation of descriptors 
 
The physicochemical properties and molecular descriptors, along with the published 
permeability data, for twenty two compounds were acquired through data mining of the 
literature available along with the use of ACD/labs database services at Daresbury, UK.  
Results from the MLC technique permitted the development of a dataset that contained logPMW 
values for 22 different compounds along with their physicochemical parameters, such as 
molecular weight (MW) and published permeability values (Kp).   
Physicochemical properties of interest for all the compounds considered in this work 
are presented in Table 7.1 while a general scheme of modeling methodology is presented in 
Figure 7.2. 
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Table 7.1: Physicochemical parameters of selected compounds 
Drug Experimental logKP Literature logPOW LogPMW MW pKa MP HA HD VM PSA 
Urea -3.8 (Martínez-Pla et al., 2003) -2.11 (Martínez-Pla et al., 2003) -0.5 60.1 14.3 134.0 3 4 49.5 69.1 
Thiourea -4.02 (Martínez-Pla et al., 2003) -0.95 (Martínez-Pla et al., 2003) -0.2 76.1 13.0 182.0 2 4 57.3 84.3 
Nicotinic acid -4.6 (Dal Pozzo et al., 1991) 0.40 (Dal Pozzo et al., 1991) -0.3 123.1 4.8 236.6 3 1 95.1 50.2 
Methyl nicotinate -2.05 (Le and Lippold, 1995) 0.80 (Le and Lippold, 1995) 1.13 137.1 3.2   39.0 3 0 120.5 39.2 
Salicylic acid -2.2 (Assessment, 1992) 2.26 (Assessment, 1992) 0.43 138.1 13.1 159.0 3 2 100.3 57.5 
Ethyl nicotinate -2.21 (Dal Pozzo et al., 1991) 1.30 (Dal Pozzo et al., 1991) 1.47 151.2 3.3     8.0 3 0 137.1 39.2 
Acetaminophen -2.75 (Assessment, 1992) 0.50 (Assessment, 1992) 0.69 151.2 9.8 170.0 2 2 105.4 49.3 
Methyl Paraben -1.21 (Nicoli et al., 2008) 1.96 (Nicoli et al., 2008) 1.15 152.1 8.4 127.0 3 1 125.7 46.5 
Sodium salicylate -4.26 (Martínez-Pla et al., 2003) 2.06 (Martínez-Pla et al., 2003) -0.01 160.1 3.0 160.0 3 1 100.3 57.5 
Ethyl paraben -1.39 (Nicoli et al., 2008) 2.47 (Nicoli et al., 2008) 1.43 166.2 8.3 117.0 3 1 142.2 46.3 
Butyl nicotinate -1.48 (Le and Lippold, 1995) 2.27 (Le and Lippold, 1995) 1.84 179.2 3.2     5.0 3 0 170.1 53.0 
Aspirin -2.14 (Degim et al., 1998) 1.19 (Degim et al., 1998) 0.91 180.2 3.5 135.0 4 1 139.5 63.6 
Caffeine -3.50 (Lian et al., 2008) -0.07 (Lian et al., 2008) 0.92 194.2 0.5 238.0 2 0 134.6 58.4 
Ibuprofen -1.4 (Degim et al., 1998) 3.57 (Waters et al., 2012) 1.74 206.3 4.4   76.0 2 1 200.3 37.3 
Hexyl nicotinate -1.09 (Le and Lippold, 1995) 3.50 (Le and Lippold, 1995) 1.91 207.3 3.2     5.0 3 0 203.1 39.2 
Naproxen -2.54 (Degim et al., 1998) 3.20 (Degim et al., 1998) 1.57 230.3 4.8 155.0 3 1 178.3 46.5 
Lidocaine -1.7 (Thomas et al., 2007) 2.40 (Thomas et al., 2007) 1.77 234.4 7.9   68.5 2 1 228.3 32.3 
Flurbiprofen -2.56 (Charoo et al., 2008) 3.70 (Waters et al., 2012) 1.68 244.3 4.1 112.0 3 1 203.6 37.3 
Ketoprofen -2.57 (Hadgraft et al., 2000) 2.70 (Waters et al., 2012) 1.46 254.3 4.2   96.0 3 1 212.2 54.4 
Diclofenac -3.1 (Hadgraft et al., 2000) 4.50 (Hadgraft et al., 2000) 1.64 296.2 3.9 157.0 3 2 182.9 49.3 
Indomethacin -3.15 (Hadgraft et al., 2000) 3.51 (Hadgraft et al., 2000) 1.88 357.8 4.2 155.0 4 1 269.5 68.5 
Haloperidol -4.04 (Azarbayjani et al., 2010) 3.49 (Azarbayjani et al., 2010) 1.57 375.9 8.3 151.5 4 1 303.2 40.5 
*MW (g/mol) is the molecular weight; pKa is the dissociation constant; MP (ºC) is the melting point; HA and HD, number of hydrogen bond acceptor and donator respectively; 
PSA (Ǻ2) is polar surface area and VM (cm3.mol-1) is the molar volume. All these descriptors were generated from ACD/Labs RSC, UK. 
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Figure 7.2: Schematic representation of modeling methodology 
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7.3.2. Inclusion of logPMW in the Potts and Guy prediction model  
 
Before developing a full-fledged prediction model, the present dataset of 22 compounds 
was fitted to the Potts and Guy prediction model (Potts and Guy, 1992) which holds the gold 
standard in modeling skin permeability based on the structure property relationship between 
physicochemical properties and permeability of compounds. 
The Potts and Guy permeability model is expressed by the following equation: 
݈݋��� = −ʹ.͹ʹ + Ͳ.͹ͳ × ݈݋�P୓W − Ͳ.ͲͲ͸ͳ × ��                            (7.4) 
where KP is the permeability coefficient, POW is the octanol – water partition coefficient and 
MW is the molecular weight. 
This was achieved in two steps: 
(i) The data of 22 compounds were fitted to the Potts and Guy model equation using 
traditional octanol-water partition coefficients (logPOW). 
(ii) The data of 22 compounds were fitted to Potts and Guy model equation using 
recently developed micelle-water partition coefficients (logPMW). 
7.3.3. Model development based on logPMW 
 
Initially, two parallel regression analyses were conducted, with experimental KP values 
regressed against logPMW or logPOW values. In both cases molecular weight was included as an 
additional covariate for consistency with previous analyses (Potts and Guy, 1992). The fit of 
both models to the data, and the predictive capability of both models (using the prediction error 
sum of squares (PRESS) statistic), were compared to determine the most appropriate partition 
coefficient for inclusion in a regression model. 
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Further multiple regression analyses were undertaken, considering additional recorded 
parameters in conjunction with the partition coefficient parameter found to provide the best 
summary of the data in the above models, to determine an optimum parsimonious model for 
the full complement of drugs in the data set. Checks for multicollinearity were performed on 
all variables before consideration for inclusion in a multiple model. Residual analysis was also 
undertaken to check the underlying regression assumptions. The variables remaining in the 
optimal model were assessed for significance and relative importance using standardised 
coefficients and associated p-values. 
As a result of the relatively small sample size, and variations in the drugs selected for 
investigation between this and previous studies, cross-validation techniques were also 
employed to assess the predictive capability of the preferred regression model. These 
techniques included determination of the Wherry adjusted R2 statistic and an approximate R2 
for prediction derived from the PRESS statistic, R2PRED, which can be used to compare a 
number of candidate model structures for the same data set. The Wherry statistic indicates how 
much variability in experimental KP values would be accounted for from a prediction equation 
derived in the population from which the sample was drawn, but does not indicate how well 
the derived equation will predict on other samples of drugs from the same population. The 
PRESS-based R2PRED statistic measures the external predictive power of the model (i.e. how 
well the model is likely to predict responses in a new experiment).  
Data splitting was not utilised as a cross-validation method, in order to avoid obtaining 
prediction equations based on the very small numbers of drugs; by contrast, the PRESS-based 
approach comprises 22 validations, each of sample size 21.  
Drugs with potentially high influence on the regression model were identified by calculation 
of Studentised residuals, leverage statistics and Cook’s distances for all drugs in the data set, 
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in order to provide insights of the suitability of the chosen drugs in the data set to derive the 
prediction model. A set of potentially highly influential drugs was derived, comprising drugs 
which met one or more of the following criteria: 
(i) Drugs whose Studentised residual lay in excess of 3 standard deviations from the 
mean (for a data set of the current size, it might be expected that about 1 observation 
would be in excess of 2 standard deviations from the mean); 
(ii) Drugs whose leverage value indicated it to be very different to other drugs in the 
sample (according to the commonly-applied criteria that a leverage value above 
2(p+1)/n, where p is the number of predictors in the model and n is the number of 
items in the sample). In the current data set, this would amount to any drug with a 
leverage of 0.272 or more, based on a set of leverage values which would be expected 
to have a mean value of 0.091; 
(iii) Drugs considered being potentially influential according to Cook’s distance, Di 
(assumed to be represented in drug i by an associated Di value of greater than 1). 
A sensitivity analysis using a reduced data set with potentially highly influential drugs was 
conducted, to determine whether these drugs had a detrimental impact on model predictive 
capability. 
7.4. Results and discussion 
 
Partition coefficient (logPMW) values for twenty two compounds considered in this 
study using MLC, as described in the previous chapters, along with the literature octanol-water 
partition coefficient (logPOW) values, published skin permeability data in terms of permeability 
coefficient (logKp) and other associated physicochemical parameters are listed in Table 7.1. 
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7.4.1. Relationship between experimental and predicted permeability using the Potts 
and Guy model  
 
Initially, traditional octanol-water partition coefficients for 22 compounds were fitted 
to the Potts and Guy (P&G) model in order to investigate if this model holds predictive ability 
beyond the dataset originally used to develop the model. Fitting data to the Potts and Guy 
equation resulted in predicted permeability coefficient values which were then compared with 
the experimental permeability coefficient values in order to probe a relationship between 
experimental and predicted values. This was achieved by applying simple linear regression on 
experimental and predicted permeability coefficient values. A summary of the statistics is given 
in Table 7.2. 
Table 7.2: Summary of the statistics 
 
It can be seen from the results of linear regression that a poor R2 and adjusted R2 
statistics were achieved when the logPOW of 22 compounds in the dataset was used in the P&G 
model for prediction of permeability coefficient. This implies that the P&G model is not an 
accurate predictor of skin permeability beyond the dataset originally used to construct this 
model. The Potts and Guy model was predominantly based on the dataset compiled by Flynn 
and co-workers (Flynn et al., 1990). This discrepancy has been highlighted by Lun Tak Lam 
Goodness of Fit Statistics P&G with logPOW  P &G with logPMW 
Observations 22 22 
Sum of weights 22 22 
DF 20 20 
R² 0.247 0.771 
Adjusted R² 0.209 0.760 
MSE 0.910 0.276 
Press RMSE 1.027 0.579 
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and co-workers in previous studies (Lam et al., 2010). They highlighted that the composition 
of the dataset has a significant effect on the outcome and nature of the derived QSPR model. 
Further to this argument, the dataset considered by Flynn and co-workers (Flynn et al., 1990) 
predominantly consisted of compounds with a logPOW value of less than 2.0. This has been 
argued by Moss and co-workers (2009) that the constrained lipophilicity parameter in the 
dataset may provide a limited picture of skin permeability, thus, limits the applicability of the 
model. 
Figure 7.3 depicts the relationship between experimental and predicted permeability 
coefficients while Table 7.3 summarises the predicted permeability coefficients as a result of 
inclusion of logPOW in the Potts and Guy model. It can be seen from the Figure 7.3 that a poor 
correlation was achieved when permeability coefficients were predicted using octanol-water 
partition coefficients as a lipophilicity descriptor in the Potts and Guy model thus endorsing a 
limited predictive capability of this model. 
 
Figure 7. 3: Simple linear regression between experimental and predicted logKP using Potts 
and Guy model after incorporation of logPOW 
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Table 7.3: Prediction using logPOW in the Potts and Guy Model 
Drug Experimental logKP Predicted logKP 
Urea -3.80 -4.58 
Thiourea -4.02 -3.95 
Nicotinic acid -4.60 -3.19 
Methyl nicotinate -2.05 -2.99 
Salicylic acid -2.20 -1.99 
Ethyl nicotinate -2.21 -2.72 
Acetaminophen -2.75 -3.29 
Methyl Paraben -1.21 -2.26 
Sodium salicylate -4.26 -2.23 
Ethyl paraben -1.39 -1.98 
Butyl nicotinate -1.48 -2.20 
Aspirin -2.14 -2.97 
Caffeine -3.50 -3.95 
Ibuprofen -1.40 -1.14 
Hexyl nicotinate -1.09 -1.49 
Naproxen -2.54 -1.85 
Lidocaine -1.70 -2.44 
Flurbiprofen -2.56 -1.58 
Ketoprofen -2.57 -2.35 
Diclofenac -3.10 -1.33 
Indomethacin -3.15 -2.41 
Haloperidol -4.04 -1.96 
 
In the second step of analysis, logPOW was replaced with the recently developed 
lipophilicity parameter, namely micelle-water partition coefficient (logPMW). Subsequently, the 
predicted permeability coefficient values were linearly regressed against the experimentally 
determined permeability coefficient values. Statistical parameters, for example R2 statistic, 
adjusted R2 statistic and PRESS statistic, were considered to compare the prediction values. A 
summary of the statistics is given in Table 7.2. 
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Simple linear regression analysis revealed an improved correlation between 
experimental and predicted permeability coefficients as shown in Figure 7.4. The predicted 
permeability coefficient values are presented in Table 7.4. This confirmed that the logPMW is a 
better predictor of skin permeability compared with the traditional logPOW owing to a close 
mimic of biological partitioning. Therefore, these initial results were the basis of developing a 
full predictive model based on multiple linear regression analysis including logPMW instead of 
logPOW along with several other physicochemical and molecular descriptors. 
 
 
Figure 7. 4: Simple linear regression between experimental and predicted logKP using Potts 
and Guy model after incorporation of logPMW 
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Table 7.4: Prediction using logPMW in the Potts and Guy Model 
Drug Experimental logKP Predicted logKP 
Urea -3.80 -3.44 
Thiourea -4.02 -3.32 
Nicotinic acid -4.60 -3.68 
Methyl nicotinate -2.05 -2.75 
Salicylic acid -2.20 -3.26 
Ethyl nicotinate -2.18 -2.59 
Acetaminophen -2.75 -3.15 
Methyl Paraben -1.21 -2.83 
Sodium salicylate -4.26 -3.70 
Ethyl paraben -1.39 -2.71 
Butyl nicotinate -1.48 -2.50 
Aspirin -2.14 -3.17 
Caffeine -3.50 -3.25 
Ibuprofen -1.40 -2.74 
Hexyl nicotinate -1.09 -2.62 
Naproxen -2.54 -3.01 
Lidocaine -1.70 -2.89 
Flurbiprofen -2.56 -3.02 
Ketoprofen -2.57 -3.23 
Diclofenac -3.10 -3.36 
Indomethacin -3.15 -3.56 
Haloperidol -4.04 -3.89 
 
7.4.2. Development of new model using Multiple Linear Regression Analysis 
 
Various physicochemical properties of drugs (Table 7.1) were considered for inclusion 
in a multiple regression model including logPMW and molecular weight, and using a backward 
elimination modeling strategy. Molar volume was found to be very strongly correlated with 
molecular weight (r = 0.940, p < 0.001), and inclusion of both these parameters in a multiple 
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regression model led to unacceptably high levels of the variance inflation factor (VIF) statistic. 
Deletion of the molar volume parameter resulted in levels of the VIF within acceptable limits; 
hence this parameter was not considered further in any subsequent analysis. Simple regression 
models with either logPMW as the sole covariate (R2 = 0.427), logPOW as the sole covariate (R2 
= 0.135), or molecular weight as the sole covariate (R2 = 0.001) did not provide a particularly 
good summary of the data. 
A regression analysis including only logPMW and molecular weight as covariates was 
found to have an R2 statistic of 0.829 (95 % confidence interval 0.716 – 0.914) and a PRESS 
statistic of 5.16. A regression analysis including only molecular weight and logPOW as 
covariates was found to have an R2 statistic of 0.350 (95 % confidence interval 0.072 – 0.628) 
and a PRESS statistic of 20.1. Hence logPMW in the presence of molecular weight provided a 
substantially better summary of the data than logPOW in the presence of molecular weight for 
the full complement of drugs in the study; and the PRESS statistics indicated the model 
including molecular weight and logPMW to show superior predictive capability to a model 
including molecular weight and logPOW.  
The unadjusted R2 statistic of 0.829 derived from the current data indicates that the fit 
of the sampled drugs to the model is good, with about 83 % of variance in the outcome measure 
being accounted for by logPMW and MW values. This value is comparable with unadjusted R2 
values obtained by several other researchers investigating the relationship between skin 
permeability and partition coefficients using a variety of different sets of drugs, reported by 
Moss et al. (2002).  
The high consistency of the adjusted R2 and R2PRED statistics does not suggest any 
evidence of model or data inadequacies in the current model. 
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The optimal parsimonious model was found to exclude all the remaining additional variables, 
with only the originally included variables of logPMW and molecular weight (MW) remaining 
in the final model. Hence this model was considered to provide the best summary of the data. 
This model also avoided inclusion of large numbers of predictor variables in an analysis based 
on a limited number of data points.  
The optimal model so obtained was as follows:  
݈݋��� = −ʹ.ʹͶ + ͳ.ͺ͵ × ݈݋�PMW − Ͳ.Ͳͳʹ͵ × ��                  (7.5) 
Hence a 1-unit increase in values of logPMW is associated with an increase of 1.83 units in log 
KP values, controlling for molecular weight. A 95% confidence interval for the logPMW 
parameter is given by (1.43, 2.27): a 95% confidence interval for the MW parameter is given 
by (-0.0162, -0.00847). 
The model illustrated in Figure 7.5 is the regression plot of experimental and predicted 
values while Figures 7.6 and 7.7 depict partial regression plots. 
 
Figure 7. 5: Regression plot of experimental logKP values against predicted logKP 
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Figure 7.6: Partial regression plots of experimental logKP values against logPMW 
Figure 7.7: Partial regression plots of experimental logKP values against MW 
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The R2PRED value of 0.786 implies that it could be expected that a model including just 
logPMW values and molecular weight would explain about 79% of the variability in 
observations made in new drugs not currently considered. This may be compared with 
variability of about 83% in the existing data set being explained by the model. Hence the overall 
predictive capability of the model appears to be very good, in terms both of the high values of 
the R2PRED statistic, and the consistency between the R2 statistics.  
The deletion of a high-leverage drug from the data set results in a negligible change to 
the adjusted R2 and the R2 for prediction values, implying the model is not dependent on “good” 
drugs for its predictive capability, and hence provides further evidence that the model should 
be reasonably robust to variations in the subset of drugs utilised in its generation. 
A residual analysis did not detect any marked relationship between residuals and 
predicted values (Figure 7.8), indicating no evidence for violation of regression assumptions. 
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Figure 7.8: Residual plot for optimal regression model 
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The magnitude of the standardised coefficients (1.301 for logPMW and 0.907 for 
molecular weight) indicated that logPMW was of greater importance in the model. Both 
covariates were statistically significant (t1 = 9.61, p < 0.001 for logPMW; t1 = 6.70, p < 0.001 for 
molecular weight), with the model F-ratio also being statistically significant (F2,19 = 46.2, p < 
0.001). 
The corresponding adjusted R2 statistic of the optimum model derived above was 0.811, 
which might be described as a large effect. The approximate R2 value for prediction based on 
the PRESS statistic was found to be 0.786: hence this statistic showed very good agreement 
with the corresponding adjusted R2 statistic. 
None of the drugs in the data set were found to have high residuals or be influential 
according to the calculated Studentised residuals or Cook’s distance values. The highest 
absolute Studentised residual (2.15), was associated with salicylic acid; while the highest value 
of Cook’s distance of 0.190 was associated with thiourea. Haloperidol was found to have a 
relatively high leverage value of 0.355 (i.e. above the calculated cut-off value for the current 
data set of 0.272). However, the predicted experimental logKP value associated with this drug 
of -4.01 was close to the actual experimental value obtained of -4.04; hence the overall 
influence of this drug on the data set would not be expected to be excessive. 
Deleting haloperidol from the data set resulted in a negligible change in the R2 statistic 
from 0.811 to 0.813 (95 % confidence interval 0.689 – 0.937); with a corresponding change in 
the R2 PRED statistic from 0.786 to 0.767.  
Although hard to compare, as datasets vary, in comparison with published data, it can 
be seen that this model is as good as, or better than, several existing models, including that of 
Potts and Guy (Potts and Guy, 1992) with an R2 value of 0.67, and Dearden et al. (Dearden, 
1990) with an R2 value of 0.83, despite the latter being based on a more complicated six 
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parameter system. It is noteworthy that using the current drug set of the current study, the 
replacement of the logPOW parameter in the equation derived by Potts and Guy with the logPMW 
parameter results in a substantially better model fit. The R2 value of 0.35 using the logPOW 
parameter indicates that only 35% of the variability in observations may be accounted for by 
logPOW and molecular weight in conjunction; less than half that accounted for by logPMW and 
molecular weight in conjunction. Furthermore, the PRESS statistic associated with the Potts 
and Guy model formulation applied to the current data set was found to be around 4 times 
greater than the corresponding statistic derived from the model formulation including the 
logPMW parameter. Hence the predictive capability of our model is substantially better than the 
Potts and Guy model. 
Several published models provide greater values for R2 using a range of alternative 
parameters (Lien and Gaot, 1995; Barratt, 1995a; Potts and Guy, 1995; Abraham et al., 1995b; 
Abraham et al., 1997). However, despite these latter models appearing to provide enhanced 
predictive qualities there are many reasons for the incorporation of this particular model in the 
prediction of skin permeability. The first of these is in the practical benefits of 
chromatographically measuring a partition coefficient compared with the more traditional 
shake-flask technique. For example, measurements are obtained with comparative rapidity, 
accuracy, precision and with reduced organic solvent waste and thus deemed both 
economically and environmentally favourable.  
7.5. Conclusion 
 
A systematic study of predicting human skin permeability of compounds using 
chromatographic measurements has been presented in this work. Incorporation of 
chromatographically derived micelle-water partition coefficients (logPMW) substantially 
improved the predictability of the existing model which was based on octanol-water partition 
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coefficients (logPOW). The correlation was even more improved when logPMW values for a 
dataset of 22 compounds were modeled in combination with their respective physicochemical 
properties. This study provides a better surrogate for predicting skin permeability based on an 
easy, fast and cheap experimental methodology, and the method holds the predictive capability 
for a wider population of drugs from the same dataset and also on different samples of drugs. 
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Chapter 8: Conclusions and future work 
 
 
Hydrophobicity is an important property of drugs, being closely related to the process 
of transportation to the target site. The most popular hydrophobic parameter is logP which is 
extensively used in pharmaceutical and biomedical sciences, for example, knowledge of logP 
values is important to study pharmacokinetics and the behaviour of xenobiotic substances in 
organisms. The logarithm of a partition coefficient has traditionally been measured in an 
octanol-water system. However, this system of measuring partition coefficients has not been 
widely accepted in research and the subsequent development of new drug entities for several 
reasons. This includes a tedious and time consuming methodology that utilises large amounts 
of materials, along with the fact octanol is an isotropic medium that cannot represent the 
anisotropic nature of biomembranes. Several chemical models have been proposed, such as 
micelles or liposomes, utilising much more complex techniques including gas chromatography, 
calorimetry, NMR and so on. All these methodologies are associated with problems in practice, 
and have therefore also not been widely accepted.  
 
More recently, the use of aqueous micellar solutions in reverse phase liquid 
chromatography gave birth to micellar liquid chromatography (MLC). Amphiphilic surfactants 
have polar head groups which favour aqueous environments and non-polar (or hydrophobic) 
tails. These surfactant monomers above a certain concentration, known as the critical micelle 
concentration (CMC), tend to aggregate to acquire a form known as micelles. Micelles offer 
different microenvironments to solutes, compounds which are hydrophilic remain outside the 
micelle while those which are hydrophobic tend to reside in the inner core of the micelle. 
Micelle liquid chromatography has traditionally been used for separation and partitioning of 
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organic compounds. The partitioning of compounds is based on the Armstrong model which 
describes three types of equilibrium i.e. between the micelle and aqueous phase, between the 
aqueous phase and stationary phase, and the micelle and stationary phase. However, prior to 
this work, only the retention factor, k’, in MLC has been used to indicate hydrophobicity, and 
PMW has not been given any attention although it is derived from the relation of the inverse of 
the capacity factor and micellar concentrations. The difference between k’ and PMW is clear as 
the former not only includes partitioning between the micelle and water, but also between the 
stationary phase and water, and between the stationary phase and micelle. Therefore, this thesis 
proposes a potential alternative to the traditional octanol-water system, to acquire partition 
coefficients for compounds of pharmaceutical relevance.  
 
MLC showed promise as a fast and reliable tool to acquire partition coefficient values. 
Most importantly, it highlighted many factors that contributed to the hydrophobicity 
determinations including hydrophobic and electrostatic interactions of the solutes bearing 
ionisable groups with the micelle. It became obvious that drugs with ionisable groups, may 
interact differently with the micelle, without changing the geometry of micelles as revealed by 
SAXS measurements, and the stationary phase, therefore, systematic control of ionisation 
through controlling the pH of the mobile phase would be extremely beneficial.  
 
Controlling the pH of the mobile phase provides various microenvironments within 
MLC. The scarcity of partition coefficients over the studied range of pH values using the 
traditional octanol-water system limited its comparison with MLC based partition coefficients. 
Therefore, software based calculated logD (clogP) values were used to compare with the 
experimental values. The pH appeared to significantly influence the partition coefficient values 
obtained from MLC, and these values showed a strong correlation with the computational logD 
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values. Furthermore, a specific influence of the nature of the stationary phase on the partition 
coefficients was seen. This is explained as cyanopropyl bonded stationary phases tend to adsorb 
less surfactant compared with ODS bonded phases, therefore the retention of compounds is 
largely based on the solute present in the bulk aqueous phase. Hydrophobic compounds would 
therefore prefer the micellar core and their retention time would be less than for those that 
prefer the aqueous phase.  
 
Experiments were conducted over a range of temperatures (295 K – 317 K) to acquire 
the thermodynamic parameters involved in the partitioning process. The partitioning of drugs 
in this study was enthalpically driven with negative ∆G values indicating the process was 
spontaneous.  
 
Finally, the newly developed partition coefficient values were evaluated for their 
biological relevance in terms of their predictability of transport of compounds through skin 
(Chapter 7). A large dataset comprising of logPMW values for 22 compounds was acquired 
through MLC and fitted with the other physicochemical parameters that are important for skin 
permeability. An improved correlation and predictability of the model compared with the Potts 
and Guy’ model was achieved, thus endorsing the suitability of MLC based micelle-water 
partition coefficients as a potential alternative to the traditional octanol-water system.  
 
It can be concluded that MLC has the ability to generate partition coefficient values in 
a shorter time with higher accuracy, and has the potential to replace the octanol-water system 
because of the partial structural resemblance of micelles to biomembranes. 
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Future work 
There are many areas of potential opportunity to expand this work, including: 
(a) Use of different surfactants 
This work reports on determining partition coefficients using an anionic surfactant, 
sodium dodecyl sulfate. There is a possibility of incorporation of cationic surfactants, 
such as cetyltrimethylammonium bromide or zwitterionic surfactants, such as Brij to 
acquire partition coefficients.  
In addition to that, mixed micellar systems comprising of anionic and cationic 
surfactants would provide additional opportunity to study the partitioning of 
compounds.    
(b) Use of different stationary phases 
Different stationary phases i.e. C8 or C18 with different pore sizes could be used to 
compare partition coefficients with values acquired using the cyano bonded stationary 
phase. This may provide values of biological relevance that could possibly mimic other 
bodily systems. 
(c) Expansion of logPMW dataset 
This thesis has described a potential application of logPMW in predicating skin 
permeability. This can be further refined by the addition of more compounds in the 
dataset. This will not only increase the predictability but also reliability of the model 
proposed. 
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a b s t r a c t
This study evaluates the potential application of micellar liquid chromatography (MLC) to predict skin
permeation with a series of model compounds. MLC has previously been found to be useful in the pre-
diction of partition coefficient values (logP) for pharmaceutical compounds, yet has not been incorpo-
rated in skin permeability models prior to this work. This article provides statistically supported data
that this technique enhances the ability to predict the permeability of similar drugs through the skin
(Kp). The replacement of a traditional physicochemical parameter, namely the octanol–water partition
coefficient (logPow) with a chromatographically determined value (logPmw), results in a quantitative par-
tition–permeability relationship that is robust to variation. MLC offers many benefits compared with the
traditional techniques employed to obtain logP values.
 2013 Elsevier B.V. All rights reserved.
1. Introduction
Drug permeation through human skin is an increasingly impor-
tant delivery route, often described by the associated permeability
coefficient (Kp). It is widely known that discrepancies often occur
between the in vivo reality (where the stratum corneum controls
the rate of intercellular passive diffusion) and in vitro based models
(Walters, 2002). Moreover, even models based on human in vivo
data can experience orders of magnitude of discrepancy from
observed data (Farahmand and Maibach, 2009) highlighting the
complexity of such phenomena. A significant body of research
exists assessing a variety of model based systems as their potential
benefits are recognised widely. These models are often described
as quantitative structure–permeability relationships (QSPRs)
(Moss et al., 2002) with their main shortfall arising from the incon-
sistency in the values used to derive them. For example, the heter-
ogeneity of the data, in terms of skin origin and experimental
conditions, has been shown to contribute to the residual variance
in existing models (Geinoz et al., 2004). In addition, drug perme-
ation through human skin is significantly influenced by the degree
and nature of charge on the drug molecule which is hard to accom-
modate within the majority of proposed models (Zhang et al.,
2012) and often studies are restricted to one specific series of com-
pounds (Hadgraft et al., 2000). This often prevents proposed
models from being more widely applicable as they are only valid
for a designated group of drugs, rather than all drugs, which would
be far more useful for analytical purposes. One particular challenge
is attempting to retain the simplicity of a model so that it is widely
used within the scientific community yet maintain the validity to
explain complex real-world data (Mitragotri et al., 2011); for
example, retaining the predictive ability of the model in the pres-
ence of transdermal enhancers (Moss et al., 2012) or different vehi-
cles (Ghafourian et al., 2010). In some cases it has even been
proposed that it may be best to apply both QSPRs and other models
such as Gaussian process-based machine learning methods (Brown
et al., 2012), with some claims that the latter may have signifi-
cantly improved predictivity compared with the former (Lam
et al., 2010). Several permeability correlation models have become
very well established in the scientific community for the prediction
of Kp and are regarded as an ideal initial step in the development
and characterisation process for pharmaceutical compounds. Often
models are based on parameters such as the lipophilicity and
molecular weight (or size) of a drug (Magnusson et al., 2004; Ng
et al., 2012; Potts and Guy, 1992; Singh and Roberts, 1996),
although other, related physicochemical parameters have been
investigated in an attempt to improve the predictivity of the mod-
els. Another approach employed to predict the ability of a drug to
permeate the skin is to employ in vitro based model systems, for
example those that have been successfully used to predict other
biological permeations; such as those based on the blood–brain
barrier (Sinkó et al., 2012), using electrokinetic chromatography
(Wang et al., 2009), simple silicone membrane skin models (Khan
et al., 2005; Waters et al., 2013) and most recently, chromato-
graphic techniques (Hidalgo-Rodríguez et al., 2013). Simple mod-
els, such as a silicone membrane, are particularly suited to
studies that require comparative values, for example, with varia-
tions in the presence of additional excipients or temperature
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changes (Waters et al., 2013) but may struggle to achieve absolute
data.
Recently, micellar liquid chromatography (MLC) has been pro-
posed as an alternative, and potentially superior, method for deter-
mining the lipophilicity of a compound by applying a modified
form of the chromatographic technique to determine micelle-
water partition coefficients (Waters and Kasprzyk-Hordern, 2010;
Waters et al., 2007). MLC is an established form of High Perfor-
mance Liquid Chromatography (HPLC) that incorporates a chosen
surfactant in the mobile phase at a series of concentrations signif-
icantly above the critical micellar concentration (CMC). This cre-
ates the formation of micelles with both hydrophobic and
hydrophilic regions within the aqueous mobile phase: i.e. a similar
environment to that present in skin. A sample of compound under
investigation is then injected into this surfactant-based mobile
phase under controlled parameters, such as buffer pH and temper-
ature. Monitoring the movement of a drug within MLC leads to a
more accurate and precise prediction of drug partitioning com-
pared with octanol–water based systems, i.e. Pow. MLC has been
shown to be a very simple, cheap and fast method for the determi-
nation of micelle-water partition coefficient values (logPmw)
(Waters et al., 2012). Furthermore, it is suitable for compounds
over a range of lipophilicities, ensuring it can be applied to the
study of a range of drugs with varying acidity or basicity with
analysis simply requiring measurement of the retention time for
the sample at each surfactant concentration. This flexibility is
essential if the technique is to be applied to predict the behaviour
of drugs as they regularly exist in a variety of ionisable forms.
Previous research has considered the application of MLC for
pharmaceutical compounds, and in some cases even to evaluate
skin permeability (Martínez-Pla et al., 2003, 2004), yet not, as in
this paper, with the incorporation of experimentally determined
logPmw values in a model to predict drug permeability, Kp. The
model developed in this work is based on a sample system com-
prised of 22 compounds with the application of statistical analysis
to develop an optimum model for predictive purposes that can be
applied to a far wider range of drugs than those identified in this
study. The replacement of logPow with logPmw, and the subsequent
model development, is intended to provide a superior estimation
of drug permeability through human skin in vivo compared with
existing models. In addition to this main benefit, MLC requires
no organic solvent, unlike octanol based measurements, and is fas-
ter to determine experimentally to an equivalent degree of
reproducibility.
2. Materials and methods
2.1. Materials
Sodium dodecyl sulphate (SDS) was the mobile phase surfactant
for all experiments, used as purchased from Fisher Scientific,
Loughborough, UK (99%) and diluted with distilled water as neces-
sary to achieve each concentration from 10 to 30 mM. The 22 com-
pounds considered in this work were: methyl nicotinate (Fluka,
Dorset, UK), acetaminophen, ethyl nicotinate, ethyl paraben,
haloperidol, indomethacin, lidocaine, methyl paraben, naproxen,
nicotinic acid, sodium salicylate (Sigma Aldrich, Dorset, UK), butyl
nicotinate, diclofenac, flurbiprofen, hexyl nicotinate, ketoprofen
(TCI, Oxford, UK), ibuprofen (BASF, Cheshire, UK), acetyl salicylic
acid (Acros Organics, Geel, Belgium), thiourea, urea (Vickers Lab.
Ltd., Pudsey, UK), caffeine and salicylic acid (Fisher, Loughborough,
UK), used as purchased with a minimum purity ofP98%, with each
at a concentration of 0.2 mM. All experiments were conducted at a
specified pH value of 5.5, chosen to mimic the pH of human skin,
with 0.1 M di-sodium hydrogen phosphate and 0.1 M sodium di-
hydrogen phosphate with 10% phosphoric acid (Sigma Aldrich,
Dorset, UK) as buffering agents. No organic modifier was used in
this work.
2.2. Micellar liquid chromatography method
A similar system to that previously reported was the basis of the
methodology employed in this study (Waters et al., 2012).
Degassed surfactant-based mobile phase was pumped through
the chromatographic system (Severn Analytical SA 6410B) with a
reverse phase cyanopropyl column (Spherisorb 5 lm,
15 cm  4.6 mm i.d.) and a flow rate of 1.35 mL per minute.
20 lL samples of 0.2 mM drug (solute) were injected via a Rheo-
dyne injector. A UV detector (Waters 2487), set at a wavelength
appropriate for each drug (221–285 nm), produced a peak indicat-
ing the retention of the solute within the column as a function of
time. Data were recorded and then analysed to obtain capacity fac-
tors and each run was repeated five times to ensure reasonable
accuracy and precision were achieved. With a fixed pH for the mo-
bile phase it should be noted that the degree of ionisation between
compounds may vary yet the pH of the solution was measured be-
fore and after the addition of each compound and confirmed to re-
main at a value of 5.5. This is also of importance when evaluating
values for logKp derived from literature sources as the pH of the
solvent may have an effect on the degree of ionisation and hence
the resultant value obtained (Zhang et al., 2012).
In agreement with previous work (Waters et al., 2012), it was
possible to calculate a value for logPmw by plotting the surfactant
concentration (after subtraction of the CMC, i.e. 8.0 mM) with the
inverse of the capacity factor. It should be noted that ionic strength
was not maintained as a constant during this work, in line with
previous studies.
2.3. Data analysis
Results from the MLC technique permitted the development of
a dataset that contained logPmw values for 22 different compounds
along with their physicochemical parameters, such as molecular
weight (MW) and published permeability values (Kp). Analysis fo-
cussed on the development of a quantitative partition–permeabil-
ity relationship. Data analysis was conducted using IBM SPSS
statistical software, Version 20.0.
Initially two parallel regression analyses were conducted, with
experimental Kp values regressed against logPmw or logPow values.
In both cases molecular weight was included as an additional
covariate for consistency with previous analyses (Potts and Guy,
1992). The fit of both models to the data, and the predictive capa-
bility of both models (using the prediction error sum of squares
(PRESS) statistic), were compared to determine the most appropri-
ate partition coefficient for inclusion in a regression model. Further
multiple regression analyses were undertaken, considering addi-
tional recorded parameters in conjunction with the partition coef-
ficient parameter found to provide the best summary of the data in
the above models, to determine an optimum parsimonious model
for the full complement of drugs in the data set. Checks for multi-
collinearity were performed on all variables before consideration
for inclusion in a multiple model. Residual analysis was also under-
taken to check the underlying regression assumptions.
The variables remaining in the optimal model were assessed for
significance and relative importance using standardised coeffi-
cients and associated p-values.
As a result of the relatively small sample size, and variations
in the drugs selected for investigation between this and previous
studies, the predictive capability of the preferred regression
model was also assessed using the Wherry adjusted-R2 statistic
and an approximate R2 for prediction, R2PRED, derived from the
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PRESS statistic, which can be used to compare a number of can-
didate model structures for the same data set. The Wherry
statistic indicates how much variability in experimental Kp val-
ues would be accounted for from a prediction equation derived
in the population from which the sample was drawn, but does
not indicate how well the derived equation will predict on other
samples of drugs from the same population. The R2PRED statistic
gives an indication of the external predictive power of the model
(i.e. how well the model is likely to predict responses in a new
experiment), and hence more accurately reflects the far wider
applicability of the model.
Drugs with potentially high influence on the regression model
were identified by calculation of Studentised residuals, leverage
statistics and Cook’s distances for all drugs in the data set, in order
to provide insights of the suitability of the chosen drugs in the data
set to derive the prediction model. A set of potentially highly influ-
ential drugs was derived, comprising drugs which met one or more
of the following criteria:
(i) Drugs whose Studentised residual lay in excess of 3 standard
deviations from the mean (for a data set of the current size,
it might be expected that about 1 observation would be in
excess than 2 standard deviations from the mean).
(ii) Drugs whose leverage value indicated it to be very different
to other drugs in the sample (according to the commonly-
applied criteria that a leverage value above 2(p + 1)/n, where
p is the number of predictors in the model and n is the num-
ber of items in the sample). In the current data set, this
would amount to any drug with a leverage of 0.272 or more,
based on a set of leverage values which would be expected
to have a mean value of 0.091.
(iii) Drugs considered to be potentially influential according to
Cook’s distance, Di (assumed to be represented in drug i by
an associated Di value of greater than 1).
A sensitivity analysis using a reduced data set with potentially
highly influential drugs was conducted, to determine whether
these drugs had a detrimental impact on model predictive
capability.
3. Results
Partitioning values for 22 compounds were measured in this
study using the micellar chromatographic technique previously
described, with the resultant calculated logPmw values shown in
Table 1. Table 1 also provides published octanol–water partition
coefficient (logPow) values, plus all associated physicochemical
parameters of the drugs analysed in the study.
A regression analyses including only molecular weight and
logPmw as covariates was found to have an R
2 statistic of 0.829
(95% confidence interval 0.716–0.914) and a PRESS statistic of
5.16. A regression analyses including only molecular weight and
logPow as covariates was found to have an R
2 statistic of 0.350
(95% confidence interval 0.072–0.628) and a PRESS statistic of
20.1. Hence logPmw in the presence of molecular weight provided
a substantially better summary of the data than logPow in the pres-
ence of molecular weight for the full complement of drugs in the
study; and the PRESS statistics indicated the model including
molecular weight and logPmw to show superior predictive capabil-
ity to a model including molecular weight and logPow.
Simple regression models with either logPmw as the sole covar-
iate (R2 = 0.427), logPow as the sole covariate (R
2 = 0.135), or molec-
ular weight as the sole covariate (R2 = 0.001) did not provide a
particularly good summary of the data.
All other measured variables on the drugs investigated in the
current study were considered for inclusion in a multiple regres-
sion model including logPmw and molecular weight, and using a
backward elimination modelling strategy. Molar volume was
found to be very strongly correlated with molecular weight
(r = 0.940, p < 0.001), and inclusion of both these parameters in a
multiple regression model led to unacceptably high levels of the
variance inflation factor (VIF) statistic. Deletion of the molar
volume parameter resulted in levels of the VIF within acceptable
limits; hence this parameter was not considered further in any
subsequent analysis.
The optimal parsimonious model was found to exclude all the
remaining additional variables, with only the originally included
variables of logPmw and molecular weight (MW) remaining in the
final model. Hence this model was considered to provide the best
Table 1
Physicochemical parameters for 22 selected drugs.
Drug Exp. logKp LogPmw MW LogPOW pKa
a MP HAa HDa VM
a (cm3 mol1) PSAa
Urea 3.8 (Martínez-Pla et al., 2003) 0.5 60.1 2.11 (Martínez-Pla et al., 2003) 14.3 134 3 4 49.5 69.1
Thiourea 4.02 (Martínez-Pla et al., 2003) 0.2 76.1 0.95 (Martínez-Pla et al., 2003) 13 182 2 4 57.3 84.3
Nicotinic acid 4.6 (Dal Pozzo et al., 1991) 0.3 123.1 0.4 (Dal Pozzo et al., 1991) 4.8 236.6 3 1 95.1 50.2
Methyl nicotinate 2.05 (Le and Lippold, 1995) 1.13 137.1 0.8 (Le and Lippold, 1995) 3.19 39 3 0 120.5 39.2
Salicylic acid 2.2 (Assessment, 1992) 0.43 138.1 2.26 (Assessment, 1992) 13.06 159 3 2 100.3 57.5
Ethyl nicotinate 2.21 (Dal Pozzo et al., 1991) 1.47 151.2 1.3 (Dal Pozzo et al., 1991) 3.3 8 3 0 137.1 39.2
Acetaminophen 2.75 (Assessment, 1992) 0.69 151.2 0.5 (Assessment, 1992) 9.86 170 2 2 105.4 49.3
Methyl Paraben 1.21 (Nicoli et al., 2008) 1.15 152.1 1.96 (Nicoli et al., 2008) 8.4 127 3 1 125.7 46.5
Sodium salicylate 4.26 (Martínez-Pla et al., 2003) 0.01 160.1 2.06 (Martínez-Pla et al., 2003) 3 160 3 1 100.3 57.5
Ethyl paraben 1.39 (Nicoli et al., 2008) 1.43 166.2 2.47 (Nicoli et al., 2008) 8.3 117 3 1 142.2 46.3
Butyl nicotinate 1.48 (Le and Lippold, 1995) 1.84 179.2 2.27 (Abraham et al., 1995) 3.2 5 3 0 170.1 53.02
Aspirin 2.14 (Degim et al., 1998) 0.91 180.15 1.19 (Degim et al., 1998) 3.5 135 4 1 139.5 63.6
Caffeine 3.50 (Lian et al., 2008) 0.92 194.2 0.07 (Lian et al., 2008) 0.52 238 2 0 134.6 58.4
Ibuprofen 1.4 (Degim et al., 1998) 1.74 206.3 3.5 (Waters et al., 2012) 4.41 76 2 1 200.3 37.3
Hexyl nicotinate 1.09 (Le and Lippold, 1995) 1.91 207.3 3.5 (Abraham et al., 1995) 3.21 5 3 0 203.1 39.2
Naproxen 2.54 (Degim et al., 1998) 1.57 230.3 3.2 (Degim et al., 1998) 4.84 155 3 1 178.3 46.5
Lidocaine 1.7 (Thomas et al., 2007) 1.77 234.4 2.4 (Thomas et al., 2007) 7.96 68.5 2 1 228.3 32.3
Flurbiprofen 2.56 (Charoo et al., 2008) 1.68 244.3 3.7 (Waters et al., 2012) 4.14 112 3 1 203.6 37.3
Ketoprofen 2.57 (Hadgraft et al., 2000) 1.46 254.3 2.7 (Waters et al., 2012) 4.23 96 3 1 212.2 54.4
Diclofenac 3.1 (Hadgraft et al., 2000) 1.64 296.2 4.5 (Hadgraft et al., 2000) 3.96 157 3 2 182.9 49.3
Indomethacin 3.15 (Hadgraft et al., 2000) 1.88 357.8 3.51 (Hadgraft et al., 2000) 4.18 155 4 1 269.5 68.5
Haloperidol 4.04 (Azarbayjani et al., 2010) 1.57 375.9 3.49 (Azarbayjani et al., 2010) 8.3 151.5 4 1 303.2 40.5
a pKa is the dissociation constant; MP the melting point; HA and HD the number of hydrogen bond acceptor and donator respectively; VM the molar volume; and PSA is the
polar surface area. All these descriptors were generated from ACD/Labs, Daresbury, UK.
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summary of the data. This model also avoided inclusion of large
numbers of predictor variables in an analysis based on a limited
number of data points.
The optimal model so obtained was as follows:
log Kp ¼ 2:24þ 1:83 log Pmw  0:0123 MW
Hence a 1-unit increase in values of logPmw is associated with
an increase of 1.83 units in logKp values, controlling for molecular
weight. A 95% confidence interval for the logPmw parameter is
given by (1.43, 2.27): a 95% confidence interval for the MW
parameter is given by (0.0162, 0.00847).
The model is illustrated in Fig. 1 (three-dimensional regression
plot) and Fig. 2 (partial regression plots) below.
A residual analysis did not detect any marked relationship
between residuals and predicted values (Fig. 3), indicating no
evidence for violation of regression assumptions.
The magnitude of the standardised coefficients (1.301 for
logPmw and 0.907 for molecular weight) indicated that logPmw
was of greater importance in the model. Both covariates were
statistically significant (t1 = 9.61, p < 0.001 for logPmw; t1 = 6.70,
p < 0.001 for molecular weight), with the model F-ratio also being
statistically significant (F2,19 = 46.2, p < 0.001).
The corresponding adjusted-R2 statistic of the optimum model
derived above was 0.811, which might be described as a large
effect. The approximate R2PRED value was found to be 0.786. The
close agreement with the corresponding adjusted-R2 statistic
indicates that the model does not over-fit the data.
None of the drugs in the data set were found to have high resid-
uals or be influential according to the calculated Studentised resid-
uals or Cook’s distance values. The highest absolute Studentised
residual (2.15), was associated with salicylic acid; while the high-
est value of Cook’s distance of 0.190 was associated with thiourea.
Haloperidol was found to have a relatively high leverage value of
0.355 (i.e. above the calculated cut-off value for the current data
set of 0.272). However, the predicted experimental logKp value
associated with this drug of 4.01 was close to the actual experi-
mental value obtained of 4.04; hence the overall influence of this
drug on the data set would not be expected to be excessive.
Deleting haloperidol from the data set resulted in a negligible
change in the R2 statistic from 0.811 to 0.813 (95% confidence
interval 0.689–0.937); with a corresponding change in the R2PRED
statistic from 0.786 to 0.767.
4. Discussion
The unadjusted R2 statistic of 0.829 derived from the current
data indicates that the fit of the sampled drugs to the model is
good, with about 83% of variance in the outcome measure being
accounted for by logPmw and MW values. This value is comparable
Fig. 1. 3-Dimensional plot of regression of experimental logKp values against
logPmw and MW.
Fig. 2. Partial regression plots of experimental logKp values against logPmw and MW.
Fig. 3. Residual plot for optimal regression model.
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with unadjusted R2 values obtained by several other researchers
investigating the relationship between skin permeability and par-
tition coefficients using a variety of different sets of drugs, reported
by Moss et al. (2002).
The high consistency of the adjusted-R2 and R2PRED statistics does
not suggest any evidence of model or data inadequacies in the cur-
rent model.
The R2PRED value of 0.786 implies that it could be expected that a
model including just logPmw values and molecular weight would
explain about 79% of the variability in observations made in new
drugs not currently considered. This may be compared with vari-
ability of about 83% in the existing data set being explained by
the model. Hence the overall predictive capability of the model ap-
pears to be very good, in terms both of the high values of the R2PRED
statistic, and the consistency between the R2 statistics.
The deletion of a high-leverage drug from the data set results in
a negligible change to the adjusted-R2 and the R2PRED values, imply-
ing the model is not dependent on a full complement of ‘‘good’’
drugs for its predictive capability, and suggests that the model
may be robust to minor variations in the subset of drugs utilised
in its generation.
Although hard to compare, as datasets vary in size, in compar-
ison with published data, it can be seen that this model is as good
as or better than several existing models, including that of Potts
and Guy (1992) with an R2 value of 0.67, and Dearden (1990) with
an R2 value of 0.83, despite the latter being based on a more com-
plicated six parameter system. It is noteworthy that using the drug
set of the current study, the replacement of the logPow parameter
in the equation derived by Potts and Guy with the logPmw param-
eter results in a substantially better model fit. The R2 value of 0.35
using the logPow parameter indicates that only 35% of the variabil-
ity in observations may be accounted for by logPow and molecular
weight in conjunction; less than half that accounted for by logPmw
and molecular weight in conjunction. Furthermore, the PRESS sta-
tistic associated with the Potts and Guy model formulation applied
to the current data set was found to be around 4 times greater than
the corresponding statistic derived from the model formulation
including the logPmw parameter. Hence the predictive capability
of our model is substantially better than the Potts and Guy model.
Several published models provide greater values for R2 using a
range of alternative parameters (Abraham et al., 1995, 1997; Barr-
att, 1995; Lien and Gaot, 1995; Potts and Guy, 1995). However, de-
spite these latter models appearing to provide enhanced predictive
qualities there are many reasons for the incorporation of this par-
ticular model in the prediction of skin permeability. The first of
these is in the practical benefits of chromatographically measuring
a partition coefficient compared with the more traditional shake-
flask technique. For example, measurements are obtained with
comparative rapidity, accurately, precisely and with reduced or-
ganic solvent waste and thus deemed both economically and envi-
ronmentally favourable. Secondly, this model is a good predictor of
the outcome not only on the set of drugs studied in this work, but,
as suggested by the R2PRED statistic, may also be applicable to other
groups of compounds, as appears to be the case with on-going
studies. This is often not considered in similar studies.
5. Conclusions
The chromatographically determined value of the octanol–
water partition coefficient (Pmw) represents a substantial improve-
ment on the traditional physicochemical parameter (Pow) in the
prediction of skin permeability coefficients in the study data set.
In addition to the octanol–water partition coefficient, molecular
weight is an important predictor of skin permeability coefficients.
Predictive analysis suggests that a model based on logPmw values
and derived from a set of 22 drugs would show good predictive
capability in a wider population of drugs, and also on a different
sample of drugs. This level of predictive capability has not been
proven in other studies utilising models based on physicochemical
parameters.
In the future it is anticipated that the ability of such systems to
predict physicochemical data in vitro will become more and more
important as the scientific community are encouraged to remove
in vivo methods of analysis. For example, the recent change in
the EU regulations on cosmetic testing have already sparked a far
wider discussion on this topic which will continue to grow over
the next few years.
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